B. Prakken, S. Albani, and A. Martini, Juvenile idiopathic arthritis, Lancet, vol.377, issue.11, pp.60244-60248, 2011.

A. Ravelli and A. Martini, Juvenile idiopathic arthritis. 369. London, England: Lancet, pp.60363-60371, 2007.

R. E. Petty, T. R. Southwood, P. Manners, J. Baum, D. N. Glass et al., International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, J Rheumatol, vol.31, pp.390-392, 2001.

P. J. Manners and C. Bower, Worldwide prevalence of juvenile arthritis why does it vary so much?, J Rheumatol, vol.29, pp.1520-1550, 2002.

S. Prahalad and D. N. Glass, A comprehensive review of the genetics of juvenile idiopathic arthritis, Pediatr Rheumatol Online J, vol.6, p.11, 2008.

P. Rosen, S. Thompson, and D. Glass, Non-HLA gene polymorphisms in juvenile rheumatoid arthritis, Clin Exp Rheumatol, vol.21, pp.650-656, 2003.

M. A. Ingersoll, A. M. Platt, S. Potteaux, and G. J. Randolph, Monocyte trafficking in acute and chronic inflammation, Trends Immunol, vol.32, pp.470-477, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-01662528

C. Auffray, M. H. Sieweke, and F. Geissmann, Blood monocytes: development, heterogeneity, and relationship with dendritic cells, Annu Rev Immunol, vol.27, pp.669-92, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00407757

S. Gordon and P. R. Taylor, Monocyte and macrophage heterogeneity, Nat Rev Immunol, vol.5, pp.953-64, 2005.

P. Gaur, A. Myles, R. Misra, and A. Aggarwal, Intermediate monocytes are increased in enthesitis-related arthritis, a category of juvenile idiopathic arthritis, Clin Exp Immunol, vol.187, pp.234-275, 2017.

C. Macaubas, K. Nguyen, C. Deshpande, C. Phillips, A. Peck et al., Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states, Clin Immunol, vol.134, pp.206-222, 2010.

E. Smolewska, J. Sta?czyk, H. Brózik, M. Biernacka-zieli?ska, B. Cebula et al., Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis, Ann Rheum Dis, vol.67, pp.762-770, 2008.

A. Lotito, A. Campa, C. Silva, M. Kiss, and S. Mello, Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis, J Rheumatol, vol.34, pp.823-853, 2007.

M. Gattorno, L. Chicha, A. Gregorio, F. Ferlito, F. Rossi et al., Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue, Rheumatology (Oxford), vol.46, pp.657-65, 2007.

N. Saxena, A. Aggarwal, and R. Misra, Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis, J Rheumatol, vol.32, pp.1349-53, 2005.

H. Varsani, A. Patel, Y. Van-kooyk, P. Woo, and L. R. Wedderburn, Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-kappaB (RANK), Rheumatology (Oxford), vol.42, pp.583-90, 2003.

L. R. Wedderburn, N. Robinson, A. Patel, H. Varsani, and P. Woo, Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis, Arthritis Rheum, vol.43, pp.765-74, 2000.

A. Ronaghy, W. De-jager, E. Zonneveld-huijssoon, M. R. Klein, F. Van-wijk et al., Vaccination leads to an aberrant FOXP3 T-cell response in non-remitting juvenile idiopathic arthritis, Ann Rheum Dis, vol.70, pp.2037-2080, 2011.

D. K. Kurahara, A. Grandinetti, L. Fujii, A. A. Tokuda, J. A. Galario et al., Visiting consultant clinics to study prevalence rates of juvenile rheumatoid arthritis and childhood systemic lupus erythematosus across dispersed geographic areas, J Rheumatol, vol.34, pp.425-434, 2007.

J. Mauldin, H. D. Cameron, D. Jeanotte, G. Solomon, and J. N. Jarvis, Chronic arthritis in children and adolescents in two Indian health service user populations

, Musculoskelet Disord, vol.5, p.30, 2004.

M. V. Iorio and C. M. Croce, MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review, EMBO Mol Med, vol.4, pp.143-59, 2012.

R. M. O'connell, D. S. Rao, and D. Baltimore, microRNA regulation of inflammatory responses, Annu Rev Immunol, vol.30, pp.295-312, 2012.

R. A. Bhanji, T. Eystathioy, E. Chan, D. B. Bloch, and M. J. Fritzler, Clinical and serological features of patients with autoantibodies to GW/P bodies, Clin Immunol, vol.125, pp.247-56, 2007.

R. Vicente, D. Noël, Y. M. Pers, F. Apparailly, and C. Jorgensen, Deregulation and therapeutic potential of microRNAs in arthritic diseases, Nat Rev Rheumatol, vol.12, pp.211-231, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01834238

S. Ono, S. Lam, M. Nagahara, and D. Hoon, Circulating microRNA biomarkers as liquid biopsy for cancer patients: Pros and cons of current assays, J Clin Med, vol.4, pp.1890-907, 2015.

D. Richard, I. Jorgensen, C. Apparailly, and F. , What do microRNAs mean for rheumatoid arthritis, Arthritis Rheum, vol.64, pp.11-20, 2012.

T. Nakasa, S. Miyaki, A. Okubo, M. Hashimoto, K. Nishida et al., Expression of microRNA-146 in rheumatoid arthritis synovial tissue, Arthritis Rheum, vol.58, pp.1284-92, 2008.

J. Stanczyk, D. Pedrioli, F. Brentano, O. Sanchez-pernaute, C. Kolling et al., Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum, vol.58, pp.1001-1010, 2008.

Y. A. Lashine, S. Salah, H. R. Aboelenein, and A. I. Abdelaziz, Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients, Lupus, vol.24, pp.240-247, 2015.

M. Ha and V. N. Kim, Regulation of microRNA biogenesis, Nat Rev Mol Cell Biol, vol.15, pp.509-533, 2014.

J. R. Neilson, G. Zheng, C. B. Burge, and P. A. Sharp, Dynamic regulation of miRNA expression in ordered stages of cellular development, Genes Dev, vol.21, pp.578-89, 2007.

S. Vasudevan, Y. Tong, and J. A. Steitz, Switching from repression to activation: microRNAs can up-regulate translation, Science, vol.318, pp.1931-1935, 2007.

D. Baltimore, M. P. Boldin, R. M. O'connell, D. S. Rao, and K. D. Taganov, MicroRNAs: new regulators of immune cell development and function, Nat Immunol, vol.9, pp.839-884, 2008.

E. Bernstein, S. Y. Kim, M. A. Carmell, E. P. Murchison, H. Alcorn et al., Dicer is essential for mouse development, Nat Genet, vol.35, pp.215-222, 2003.

N. L. Garneau, J. Wilusz, and C. J. Wilusz, The highways and byways of mRNA decay, Nat Rev Mol Cell Biol, vol.8, pp.113-139, 2007.

D. P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, vol.116, pp.45-50, 2004.

J. G. Ruby, C. H. Jan, and D. P. Bartel, Intronic microRNA precursors that bypass Drosha processing, Nature, vol.448, pp.83-89, 2007.

Y. Lee, C. Ahn, J. Han, H. Choi, J. Kim et al., The nuclear RNase III Drosha initiates microRNA processing, Nature, vol.425, pp.415-424, 2003.

R. Yi, Y. Qin, I. G. Macara, and B. R. Cullen, Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs, Genes Dev, vol.17, pp.3011-3017, 2003.

X. Zhou, X. Duan, J. Qian, and F. Li, Abundant conserved microRNA target sites in the 5?-untranslated region and coding sequence, Genetica, vol.137, pp.159-64, 2009.

U. A. Ørom, F. C. Nielsen, and A. H. Lund, MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation, Mol Cell, vol.30, pp.460-71, 2008.

J. R. Lytle, T. A. Yario, and J. A. Steitz, Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR, Proc Natl Acad Sci U S A, vol.104, pp.9667-72, 2007.

S. W. Chi, J. B. Zang, A. Mele, and R. B. Darnell, Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps, Nature, vol.460, pp.479-86, 2009.

C. Lin, L. Liu, J. B. Addison, W. F. Wonderlin, A. V. Ivanov et al., A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context, Mol Cell Biol, vol.31, pp.2513-2540, 2011.

E. S. Machlin, P. Sarnow, and S. M. Sagan, Masking the 5? terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex, Proc Natl Acad Sci U S A, vol.108, pp.3193-3201, 2011.

S. Vasudevan, Y. Tong, and J. A. Steitz, Cell-cycle control of microRNA-mediated translation regulation, Cell Cycle, vol.7, pp.1545-1554, 2008.

S. Vasudevan, Posttranscriptional upregulation by microRNAs, Wiley Interdiscip Rev RNA, vol.3, pp.311-341, 2012.

G. D. Kalliolias and L. B. Ivashkiv, TNF biology, pathogenic mechanisms and emerging therapeutic strategies, Nat Rev Rheumatol, vol.12, pp.49-62, 2016.

R. C. Kamm and A. G. Smith, Nucleic acid concentrations in normal human plasma, Clin Chem, vol.18, pp.519-541, 1972.

N. Nziza,

M. Hanke, K. Hoefig, H. Merz, A. C. Feller, I. Kausch et al., A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer, Urol Oncol Semin Orig Investig, vol.28, pp.655-61, 2010.

M. A. Cortez and G. A. Calin, MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases, Expert Opin Biol Ther, vol.9, pp.703-714, 2009.

N. J. Park, H. Zhou, D. Elashoff, B. S. Henson, D. A. Kastratovic et al., Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection, Clin Cancer Res, vol.15, pp.5473-5480, 2009.

J. A. Weber, D. H. Baxter, S. Zhang, D. Y. Huang, K. H. Huang et al., The microRNA spectrum in 12 body fluids, Clin Chem, vol.56, pp.1733-1774, 2010.

K. Murata, H. Yoshitomi, S. Tanida, M. Ishikawa, K. Nishitani et al., Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis, Arthritis Res Ther, vol.12, p.86, 2010.

E. E. Creemers, A. J. Tijsen, and Y. M. Pinto, Circulating MicroRNAs, Circ Res, vol.110, pp.483-95, 2012.

R. Dai and S. A. Ahmed, MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases, Transl Res, vol.157, pp.163-79, 2011.

E. Tsitsiou and M. A. Lindsay, microRNAs and the immune response, Curr Opin Pharmacol, vol.9, pp.514-534, 2009.

C. Xiao and K. Rajewsky, MicroRNA control in the immune system: basic principles, Cell, vol.136, pp.26-36, 2009.

C. Chen, L. Li, H. F. Lodish, and D. P. Bartel, MicroRNAs modulate hematopoietic lineage differentiation, Science, vol.303, pp.83-89, 2004.

K. Chen and N. Rajewsky, The evolution of gene regulation by transcription factors and microRNAs, Nat Rev Genet, vol.8, pp.93-103, 2007.

R. Niwa and F. J. Slack, The evolution of animal microRNA function, Curr Opin Genet Dev, vol.17, pp.145-50, 2007.

S. Akira, S. Uematsu, and O. Takeuchi, Pathogen recognition and innate immunity, Cell, vol.124, pp.783-801, 2006.

T. Kawai, S. Akira, and . Tlr, Cell Death Differ, vol.13, pp.816-841, 2006.

K. Takeda and S. Akira, Toll-like receptors in innate immunity, Int Immunol, vol.17, pp.1-14, 2005.

M. P. Gantier, A. J. Sadler, and B. Williams, Fine-tuning of the innate immune response by microRNAs, Immunol Cell Biol, vol.85, pp.458-62, 2007.

K. D. Taganov, M. P. Boldin, K. Chang, and D. Baltimore, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc Natl Acad Sci, vol.103, pp.12481-12487, 2006.

R. M. O'connell, K. D. Taganov, M. P. Boldin, G. Cheng, and D. Baltimore, MicroRNA-155 is induced during the macrophage inflammatory response, Proc Natl Acad Sci U S A, vol.104, pp.1604-1613, 2007.

E. Tili, J. Michaille, A. Cimino, S. Costinean, C. D. Dumitru et al., Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock, J Immunol, vol.179, pp.5082-5091, 2007.

M. Ceppi, P. M. Pereira, I. Dunand-sauthier, E. Barras, W. Reith et al., MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells, Proc Natl Acad Sci U S A, vol.106, pp.2735-2775, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00407802

M. L. Turner, F. M. Schnorfeil, and T. Brocker, MicroRNAs regulate dendritic cell differentiation and function, J Immunol, vol.187, pp.3911-3918, 2011.

P. Jin, T. H. Han, J. Ren, S. Saunders, E. Wang et al., Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies, J Transl Med, vol.8, 2010.

B. S. Cobb, T. B. Nesterova, E. Thompson, A. Hertweck, E. O'connor et al., T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer, J Exp Med, vol.201, pp.1367-73, 2005.

S. A. Muljo, K. M. Ansel, C. Kanellopoulou, D. M. Livingston, A. Rao et al., Aberrant T cell differentiation in the absence of Dicer, J Exp Med, vol.202, pp.261-270, 2005.

S. B. Koralov, S. A. Muljo, G. R. Galler, A. Krek, T. Chakraborty et al., Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage, Cell, vol.132, pp.860-74, 2008.

S. Monticelli, K. M. Ansel, C. Xiao, N. D. Socci, A. M. Krichevsky et al., MicroRNA profiling of the murine hematopoietic system, Genome Biol, vol.6, p.71, 2005.

L. Lu, M. P. Boldin, A. Chaudhry, L. Lin, K. D. Taganov et al., Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses, Cell, vol.142, pp.914-943, 2010.

J. L. Zhao, D. S. Rao, M. P. Boldin, K. D. Taganov, R. M. O'connell et al., NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies, Proc Natl Acad Sci U S A, vol.108, pp.9184-9193, 2011.

A. Rodriguez, E. Vigorito, C. S. Warren, M. V. Couttet, P. Soond et al., Requirement of bic/microRNA-155 for normal immune function, Science, vol.316, pp.608-619, 2007.

T. Thai, D. P. Calado, S. Casola, K. M. Ansel, C. Xiao et al., Regulation of the germinal center response by microRNA-155, Science, vol.316, pp.604-612, 2007.

S. Kohlhaas, O. A. Garden, C. Scudamore, M. Turner, K. Okkenhaug et al., Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells, J Immunol, vol.182, pp.2578-82, 2009.

Y. Dorsett, K. M. Mcbride, M. Jankovic, A. Gazumyan, T. Thai et al., MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation, Immunity, vol.28, pp.630-638, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00350863

K. Calame, MicroRNA-155 function in B cells, Immunity, vol.27, pp.825-832, 2007.

E. Vigorito, K. L. Perks, C. Abreu-goodger, S. Bunting, Z. Xiang et al., microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells, Immunity, vol.27, pp.847-59, 2007.

C. C. Goodnow, Multistep pathogenesis of autoimmune disease, Cell, vol.130, pp.25-35, 2007.

M. J. Shlomchik, J. E. Craft, and M. J. Mamula, From T to B and back again: positive feedback in systemic autoimmune disease, Nat Rev Immunol, vol.1, pp.147-53, 2001.

X. Zhou, L. T. Jeker, B. T. Fife, S. Zhu, M. S. Anderson et al., Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity, J Exp Med, vol.205, pp.1983-91, 2008.

A. V. Churov, E. K. Oleinik, and M. Knip, MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential, Autoimmun Rev, vol.14, pp.1029-1066, 2015.

R. P. Singh, I. Massachi, S. Manickavel, S. Singh, N. P. Rao et al., The role of miRNA in inflammation and autoimmunity, Autoimmun Rev, vol.12, pp.1160-1165, 2013.

J. Q. Chen, G. Papp, P. Szodoray, and M. Zeher, The role of microRNAs in the pathogenesis of autoimmune diseases, Autoimmun Rev, vol.15, pp.1171-80, 2016.

Y. Kamiya, J. Kawada, Y. Kawano, Y. Torii, S. Kawabe et al., Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis, Clin Rheumatol, vol.34, pp.1705-1717, 2015.

H. Shibuya, T. Nakasa, N. Adachi, Y. Nagata, M. Ishikawa et al., Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation, Mod Rheumatol, vol.23, pp.674-85, 2013.

M. Filková, B. Aradi, L. Senolt, C. Ospelt, S. Vettori et al., Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis, Ann Rheum Dis, vol.73, pp.1898-904, 2014.

H. Wang, W. Peng, X. Ouyang, W. Li, and Y. Dai, Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus, Transl Res, vol.160, pp.198-206, 2012.

D. Lagos, G. Pollara, S. Henderson, F. Gratrix, M. Fabani et al., miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator, Nat Cell Biol, vol.12, pp.513-522, 2010.

X. Jia, H. Ouyang, B. A. Abdalla, H. Xu, Q. Nie et al., miR-16 controls myoblast proliferation and apoptosis through directly suppressing Bcl2 and FOXO1 activities, Biochim Biophys Acta Gene Regul Mech, vol.1860, pp.674-84, 2017.

Q. Jing, S. Huang, S. Guth, T. Zarubin, A. Motoyama et al., Involvement of microRNA in AU-rich element-mediated mRNA instability, Cell, vol.120, pp.623-657, 2005.

M. Dunaeva, J. Blom, R. Thurlings, and G. Pruijn, Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis, Clin Exp Immunol, vol.193, pp.376-85, 2018.

X. Ma, F. Wu, L. Xin, G. Su, F. He et al., Differential plasma microRNAs expression in juvenile idiopathic arthritis, Mod Rheumatol, vol.26, pp.1-9, 2015.

R. Zhou, X. Li, G. Hu, A. Gong, K. M. Drescher et al., PLoS One, vol.7, 2012.

J. Sun, M. Feng, F. Wu, X. Ma, J. Lu et al., Plasma miR-26a as a diagnostic biomarker regulates cytokine expression in systemic juvenile idiopathic arthritis, J Rheumatol, vol.43, pp.1607-1621, 2016.

D. H. Lee, S. Amanat, C. Goff, L. M. Weiss, J. W. Said et al., Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival, Oncogenesis, vol.2, 2013.

K. Kim, J. H. Kim, I. Kim, J. Lee, S. Seong et al., MicroRNA-26a regulates RANKL-induced osteoclast formation, Mol Cell, vol.38, pp.75-80, 2015.

C. Jiang, W. Zhu, J. Xu, B. Wang, W. Hou et al., MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats, Arthritis Res Ther, vol.16, p.9, 2014.

Y. Lin, C. Wang, M. E. Gershwin, and B. Chiang, The pathogenesis of oligoarticular/ polyarticular vs systemic juvenile idiopathic arthritis, Autoimmun Rev, vol.10, pp.482-491, 2011.

K. Murata, M. Furu, H. Yoshitomi, M. Ishikawa, H. Shibuya et al., Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis, PLoS One, vol.8, 2013.

B. Hong, S. You, S. Yoo, D. Park, D. Hwang et al., MicroRNA-143 and N. Nziza, et al. -145 modulate the phenotype of synovial fibroblasts in rheumatoid arthritis, Exp Mol Med, vol.49, 2017.

B. Yang, X. Kang, Y. Xing, C. Dou, F. Kang et al., Effect of microRNA-145 on IL-1?-induced cartilage degradation in human chondrocytes, FEBS Lett, vol.588, pp.2344-52, 2014.

H. Li, Y. Xie, F. Li, G. Sun, Z. Chen et al., Effect of miR-19a and miR-21 on the JAK/STAT signaling pathway in the peripheral blood mononuclear cells of patients with systemic juvenile idiopathic arthritis, Exp Ther Med, vol.11, pp.2531-2537, 2016.

T. X. Lu, J. Hartner, E. Lim, V. Fabry, M. K. Mingler et al., MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity, J Immunol, vol.187, pp.3362-73, 2011.

D. Iliopoulos, S. A. Jaeger, H. A. Hirsch, M. L. Bulyk, and K. Struhl, STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer, Mol Cell, vol.39, pp.493-506, 2010.

L. Dong, X. Wang, J. Tan, H. Li, W. Qian et al., Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis, J Cell Mol Med, vol.18, pp.2213-2237, 2014.

L. Philippe, G. Alsaleh, G. Suffert, A. Meyer, P. Georgel et al., TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes, J Immunol, vol.188, pp.454-61, 2012.

V. Christen, S. Treves, F. Duong, and M. H. Heim, Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A, Hepatology, vol.46, pp.558-65, 2007.

J. C. Crispín, S. A. Apostolidis, F. Rosetti, M. Keszei, N. Wang et al., Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism, J Immunol, vol.188, pp.3567-71, 2012.

C. G. Katsiari, V. C. Kyttaris, Y. Juang, and G. C. Tsokos, Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus, J Clin Invest, vol.115, pp.3193-204, 2005.

K. M. Pauley, M. Satoh, A. L. Chan, M. R. Bubb, W. H. Reeves et al., Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients, Arthritis Res Ther, vol.10, p.101, 2008.

G. S. Schulert, N. Fall, J. B. Harley, N. Shen, D. J. Lovell et al., Monocyte MicroRNA expression in active systemic juvenile idiopathic arthritis implicates MicroRNA-125a-5p in polarized monocyte phenotypes, Arthritis Rheum, vol.68, pp.2300-2313, 2016.

S. Banerjee, H. Cui, N. Xie, Z. Tan, S. Yang et al., miR-125a-5p regulates differential activation of macrophages and inflammation, J Biol Chem, vol.288, pp.35428-35464, 2013.

W. Xie, M. Li, N. Xu, Q. Lv, N. Huang et al., MiR-181a regulates inflammation responses in monocytes and macrophages, PLoS One, vol.8, 2013.

T. Do, R. Tan, M. Bennett, M. Medvedovic, A. A. Grom et al., MicroRNA networks associated with active systemic juvenile idiopathic arthritis regulate CD163 expression and anti-inflammatory functions in macrophages through two distinct mechanisms, J Leukoc Biol, vol.103, pp.71-85, 2018.

H. Van-gorp, P. L. Delputte, and H. J. Nauwynck, Scavenger receptor CD163, a Jack-of-alltrades and potential target for cell-directed therapy, Mol Immunol, vol.47, pp.1650-60, 2010.

S. Kim, K. Ramasamy, H. Bouamar, A. Lin, D. Jiang et al., MicroRNAs miR-125a and miR-125b constitutively activate the NF-?B pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20), Proc Natl Acad Sci U S A, vol.109, pp.7865-70, 2012.

L. Peng, W. Ma, F. Yi, Y. Yang, W. Lin et al., MicroRNA profiling in Chinese patients with primary Sjögren syndrome reveals elevated miRNA-181a in peripheral blood mononuclear cells, J Rheumatol, vol.41, pp.2208-2221, 2014.

M. B. Løvendorf, H. Mitsui, J. R. Zibert, M. A. Røpke, M. Hafner et al., Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis, Exp Dermatol, vol.24, pp.187-93, 2015.

A. Abou-zeid, M. Saad, and E. Soliman, MicroRNA 146a expression in rheumatoid arthritis: association with tumor necrosis factor-alpha and disease activity, Genet Test Mol Biomarkers, vol.15, pp.807-819, 2011.

T. Niimoto, T. Nakasa, M. Ishikawa, A. Okuhara, B. Izumi et al., MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients, BMC Musculoskelet Disord, vol.11, p.209, 2010.

P. Manoharan, J. E. Basford, R. Pilcher-roberts, J. Neumann, D. Y. Hui et al., Reduced levels of microRNAs miR-124a and miR-150 are associated with increased proinflammatory mediator expression in Krüppel-like factor 2 (KLF2)-deficient macrophages, J Biol Chem, vol.289, pp.31638-31684, 2014.

D. Vasilatou, S. Papageorgiou, V. Pappa, E. Papageorgiou, and J. Dervenoulas, The role of microRNAs in normal and malignant hematopoiesis, Eur J Haematol, vol.84, pp.1-16, 2010.

C. Liu, Y. Sun, J. Li, Y. Gong, K. T. Tian et al., Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization, Proc Natl Acad Sci U S A, vol.112, pp.12163-12171, 2015.

N. Tano, H. W. Kim, and M. Ashraf, microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4, PLoS One, vol.6, 2011.

G. Turcatel, N. Rubin, A. El-hashash, and D. Warburton, MIR-99a and MIR-99b modulate TGF-? induced epithelial to mesenchymal plasticity in normal murine mammary gland cells, PLoS One, vol.7, 2012.

Y. Zeng, X. Qu, H. Li, S. Huang, S. Wang et al., MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2, FEBS Lett, vol.586, pp.2375-81, 2012.

S. C. Warth, K. P. Hoefig, A. Hiekel, S. Schallenberg, K. Jovanovic et al., Induced miR-99a expression represses Mtor cooperatively with miR-150 to promote regulatory T-cell differentiation, EMBO J, vol.34, pp.1195-213, 2015.

J. Ogando, M. Tardáguila, A. Díaz-alderete, A. Usategui, V. Miranda-ramos et al., Notch-regulated miR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients, Sci Rep, vol.6, p.20223, 2016.

I. Duroux-richard, Y. Pers, S. Fabre, M. Ammari, D. Baeten et al., Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis, Mediat Inflamm, p.342524, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01845068

S. Bandyopadhyay, T. Lane, R. Venugopal, P. T. Parthasarathy, Y. Cho et al., MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2, Biochem Biophys Res Commun, vol.439, pp.407-419, 2013.

Z. Li, M. Q. Hassan, S. Volinia, A. J. Van-wijnen, J. L. Stein et al., A microRNA signature for a BMP2-induced osteoblast lineage commitment program, Proc Natl Acad Sci U S A, vol.105, pp.13906-13917, 2008.

Y. Nakamachi, S. Kawano, M. Takenokuchi, K. Nishimura, Y. Sakai et al., MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis, Arthritis Rheum, vol.60, pp.1294-304, 2009.

L. Maggi, L. Cosmi, G. Simonini, F. Annunziato, and R. Cimaz, T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies

, Autoimmun Rev, vol.15, pp.1141-1145, 2016.

C. Aupiais, B. Ilharreborde, C. Doit, A. Blachier, M. Desmarest et al., Aetiology of arthritis in hospitalised children: an observational study, Arch. Dis. Child, vol.100, pp.742-747, 2015.

C. Wall and L. Donnan, Septic arthritis in children, Aust. Fam. Physician, vol.44, pp.213-215, 2015.

, June, vol.28, 2018.

M. Al-qwbani, N. Jiang, and B. Yu, Kingella kingae-Associated Pediatric Osteoarticular Infections: An Overview of 566 Reported Cases, Clin. Pediatr. (Phila), vol.55, pp.1328-1337, 2016.

R. E. Petty, T. R. Southwood, P. Manners, J. Baum, D. N. Glass et al.,

J. Maldonado-cocco, A. Orozco-alcala, M. E. Prieur, P. Suarez-almazor, and I. L. Woo, for International League of Associations for Rheumatology, International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, J. Rheumatol, vol.31, pp.390-392, 2001.

, June, vol.22, 2018.

B. Prakken, S. Albani, and A. Martini, Juvenile idiopathic arthritis, Lancet, vol.377, pp.2138-2149, 2011.

C. Hémont, A. Neel, M. Heslan, C. Braudeau, and R. Josien, Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness, J. Leukoc. Biol, vol.93, pp.599-609, 2013.

S. L. Jongbloed, A. J. Kassianos, K. J. Mcdonald, G. J. Clark, X. Ju et al., BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens, J. Exp. Med, vol.141, pp.1247-1260, 2010.

H. Lauterbach, B. Bathke, S. Gilles, C. Traidl-hoffmann, C. A. Luber et al.,

G. M. Freudenberg, D. Davey, A. Vremec, L. Kallies, K. Wu et al., Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC, J. Exp. Med, vol.207, pp.2703-2720, 2010.

T. S. Mathan, C. G. Figdor, and S. I. Buschow, Human Plasmacytoid Dendritic Cells: From Molecules to Intercellular Communication Network, Front. Immunol, vol.4, p.372, 2013.

!. Doi,

Z. Yin, J. Dai, J. Deng, F. Sheikh, M. Natalia et al., Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells, J. Immunol, vol.189, pp.2735-2745, 2012.

E. M. Coccia, M. Severa, E. Giacomini, D. Monneron, M. E. Remoli et al.,

G. Lande and . Uzé, Viral infection and Toll-like receptor agonists induce a differential expression of type I and ? interferons in human plasmacytoid and monocyte-derived dendritic cells, Eur. J

, Immunol, vol.34, pp.796-805, 2004.

C. Macaubas, K. Nguyen, C. Deshpande, C. Phillips, A. Peck et al., Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states, Clin. Immunol, vol.134, pp.206-222, 2010.

E. Smolewska, J. Sta?czyk, H. Brózik, M. Biernacka-zieli?ska, B. Cebula et al., Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis, Ann. Rheum. Dis, vol.67, pp.762-770, 2008.

E. Segura, M. Touzot, A. Bohineust, A. Cappuccio, G. Chiocchia et al.,

S. Soumelis and . Amigorena, Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation, Immunity, vol.38, pp.336-348, 2013.

G. Reynolds, J. R. Gibbon, A. G. Pratt, M. J. Wood, D. Coady et al., Synovial CD4+ Tcell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis, Ann. Rheum. Dis, vol.75, pp.899-907, 2016.

K. L. Wong, J. J. Tai, W. Wong, H. Han, X. Sem et al., Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets, Blood, vol.118, pp.16-31, 2011.

L. M. Carlin, E. G. Stamatiades, C. Auffray, R. N. Hanna, L. Glover et al.,

H. T. Hedrick, S. Cook, F. Diebold, and . Geissmann, Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal, Cell, vol.153, pp.362-75, 2013.

C. Auffray, D. Fogg, M. Garfa, G. Elain, O. Join-lambert et al., Monitoring of blood vessels and tissues by a population of ! kD! monocytes with patrolling behavior, Science, vol.317, pp.666-70, 2007.

F. Geissmann, S. Jung, and D. R. Littman, Blood monocytes consist of two principal subsets with distinct migratory properties, Immunity, vol.19, pp.71-82, 2003.

, June, vol.28, 2018.

J. Cros, N. Cagnard, K. Woollard, N. Patey, S. Zhang et al., Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors, Immunity, vol.33, pp.375-86, 2010.

K. L. Wong, W. H. Yeap, J. J. Tai, S. M. Ong, T. M. Dang et al., The three human monocyte subsets: implications for health and disease, Immunol. Res, vol.53, pp.41-57, 2012.

J. Skrzeczynska, K. Kobylarz, Z. Hartwich, M. Zembala, and J. Pryjma, CD14+CD16+ Monocytes in the Course of Sepsis in Neonates and Small Children: Monitoring and Functional Studies, Scand. J. Immunol, vol.55, pp.629-638, 2002.

B. Smiljanovic, A. Radzikowska, E. Kuca-warnawin, W. Kurowska, J. R. Grün et al.,

K. Ohrndorf, M. Aupperle, G. R. Backhaus, A. Burmester, A. Radbruch et al.,

T. Maslinski and . Häupl, Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint, Ann. Rheum. Dis, vol.77, pp.300-308, 2018.

P. Gaur, A. Myles, R. Misra, and A. Aggarwal, Intermediate monocytes are increased in enthesitisrelated arthritis, a category of juvenile idiopathic arthritis, Clin. Exp. Immunol, vol.187, pp.234-241, 2017.

B. R. Yoon, S. Yoo, Y. Choi, Y. Chung, J. Kim et al., Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA), vol.9, p.109775, 2014.

M. Rossol, S. Kraus, M. Pierer, C. Baerwald, and U. Wagner, The CD14 bright CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population, Arthritis Rheum, vol.64, pp.671-677, 2012.

W. Jager, E. P. Hoppenreijs, N. M. Wulffraat, L. R. Wedderburn, W. Kuis et al., Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study, Ann. Rheum. Dis, vol.66, pp.589-98, 2007.

C. Aupiais, R. Basmaci, B. Ilharreborde, A. Blachier, M. Desmarest et al., Arthritis in children: comparison of clinical and biological characteristics of septic arthritis and juvenile idiopathic arthritis, Arch. Dis. Child, vol.102, pp.316-322, 2017.

S. Tyanova, T. Temu, P. Sinitcyn, A. Carlson, M. Y. Hein et al., The Perseus computational platform for comprehensive analysis of (prote)omics data, Nat. Methods, vol.13, pp.731-740, 2016.

J. A. Hanley and B. J. Mcneil, The meaning and use of the area under a receiver operating characteristic (ROC) curve, Radiology, vol.143, pp.29-36, 1982.

F. Gohar, C. Kessel, M. Lavric, D. Holzinger, and D. Foell, Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?, Arthritis Res. Ther, vol.18, p.163, 2016.

J. C. Nguyen, K. S. Lee, M. M. Thapa, and H. G. Rosas, US Evaluation of Juvenile Idiopathic Arthritis and Osteoarticular Infection, RadioGraphics, vol.37, pp.1181-1201, 2017.

J. C. Alves-filho, F. Spiller, and F. Q. Cunha, Neutrophil paralysis in sepsis, Shock, vol.34, pp.15-21, 2010.

A. Gregorio, C. Gambini, V. Gerloni, A. Parafioriti, M. P. Sormani et al., Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration, Rheumatology, vol.46, pp.308-313, 2006.

L. R. Wedderburn, N. Robinson, A. Patel, H. Varsani, and P. Woo, Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis, Arthritis Rheum, vol.43, p.765, 2000.

M. B. Ka, D. Olive, and J. Mege, Modulation of monocyte subsets in infectious diseases, World J. Immunol, vol.4, p.185, 2014.

O. Kim, A. Monsel, M. Bertrand, P. Coriat, J. Cavaillon et al., Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation, Crit. Care, vol.14, p.61, 2010.

Y. Li, P. Y. Lee, E. S. Kellner, M. Paulus, J. Switanek et al.,

M. Segal, W. H. Satoh, and . Reeves, Monocyte surface expression of Fcgamma receptor RI (CD64), reflecting type-I interferon levels in systemic lupus erythematosus, Arthritis Res

. Ther, , vol.12, p.90, 2010.

S. Tanaka, J. Nishino, T. Matsui, A. Komiya, K. Nishimura et al., Neutrophil CD64 expression in the diagnosis of local musculoskeletal infection and the impact of antibiotics, J. Bone Joint Surg. Br. 91-B, pp.1237-1242, 2009.

S. Li, Y. Yu, Y. Yue, Z. Zhang, and K. Su, Microbial Infection and Rheumatoid Arthritis, J. Clin. Cell. Immunol, vol.4, 2013.

O. Oppegaard, B. Skodvin, A. Halse, and N. Langeland, CD64 as a potential biomarker in septic arthritis, BMC Infect. Dis, vol.13, p.278, 2013.

G. Fjaertoft, L. Håkansson, U. Ewald, T. Foucard, and P. Venge, Neutrophils from Term and Preterm Newborn Infants Express the High Affinity Fc?-Receptor I (CD64) During Bacterial Infections, Pediatr. Res, vol.45, pp.871-876, 1999.

G. Fjaertoft, L. Håkansson, K. Pauksens, G. Sisask, and P. Venge, Neutrophil CD64 (Fc?RI) expression is a specific marker of bacterial infection: A study on the kinetics and the impact of major surgery, Scand, J. Infect. Dis, vol.39, pp.525-535, 2007.

M. Groselj-grenc, A. Ihan, M. Pavcnik-arnol, A. N. Kopitar, T. Gmeiner-stopar et al., Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children, Intensive Care Med, vol.35, pp.1950-1958, 2009.

T. P. Hofer, A. M. Zawada, M. Frankenberger, K. Skokann, A. A. Satzl et al., slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation, vol.126, pp.2601-2610, 2015.

A. A. Throm, H. Moncrieffe, A. B. Orandi, J. T. Pingel, T. L. Geurs et al.,

O. N. Daugherty, D. J. Malkova, S. D. Lovell, A. A. Thompson, M. A. Grom et al., Identification of enhanced IFN-? signaling in polyarticular juvenile idiopathic arthritis with mass cytometry, JCI Insight, vol.3, 2018.

M. Canavan, A. M. Walsh, V. Bhargava, S. M. Wade, T. Mcgarry et al.,

. Fearon, Enriched CD141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis, JCI Insight, vol.3, 2018.

J. A. Villadangos and L. Young, Antigen-Presentation Properties of Plasmacytoid Dendritic Cells, ! kk! Immunity, vol.29, pp.352-361, 2008.

M. Swiecki and M. Colonna, The multifaceted biology of plasmacytoid dendritic cells, Nat. Rev. Immunol, vol.15, pp.471-485, 2015.

S. Hanabuchi, T. Ito, W. Park, N. Watanabe, J. L. Shaw et al., Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus, J. Immunol, vol.184, pp.2999-3007, 2010.

E. Martín-gayo, E. Sierra-filardi, A. L. Corbí, and M. L. Toribio, Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development, Blood, vol.115, pp.5366-75, 2010.

E. A. Moseman, X. Liang, A. J. Dawson, A. Panoskaltsis-mortari, A. M. Krieg et al.,

W. Blazar and . Chen, Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells, J. Immunol, vol.173, pp.4433-4442, 2004.

, June, vol.28, 2018.

M. Kavousanaki, A. Makrigiannakis, D. Boumpas, and P. Verginis, Novel role of plasmacytoid dendritic cells in humans: Induction of interleukin-10â?"producing treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy, Arthritis Rheum, vol.62, pp.53-63, 2010.

L. Van-bon, A. J. Affandi, J. Broen, R. B. Christmann, R. J. Marijnissen et al.,

T. Hesselstrand, M. Saxne, D. Dimarzio, S. K. Wuttge, J. D. Agarwal et al.,

Y. Mayes, J. P. Deng, J. Drenth, M. De-graaf, C. G. Heijer et al.,

W. B. Loof, . Van-den, L. A. Berg, V. Joosten, F. Smith et al.,

R. Trojanowska, T. R. Lafyatis, and . Radstake, Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis, N. Engl. J. Med, vol.370, pp.433-443, 2014.

M. Gilliet, W. Cao, and Y. Liu, Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases, Nat. Rev. Immunol, vol.8, pp.594-606, 2008.

J. Gottenberg, N. Cagnard, C. Lucchesi, F. Letourneur, S. Mistou et al., Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target ! #FF! organs of primary Sjögren's syndrome, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.2770-2775, 2006.

C. M. López-de-padilla, A. N. Vallejo, K. T. Mcnallan, R. Vehe, S. A. Smith et al., Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis, Arthritis Rheum, vol.56, pp.1658-1668, 2007.

A. Boltjes and F. Van-wijk, Human Dendritic Cell Functional Specialization in Steady-State and Inflammation, Front. Immunol, vol.5, p.131, 2014.

D. Ganguly, S. Haak, V. Sisirak, and B. Reizis, The role of dendritic cells in autoimmunity, Nat. Rev. Immunol, vol.13, pp.566-577, 2013.

Y. Latchman, C. R. Wood, T. Chernova, D. Chaudhary, M. Borde et al.,

N. Carreno, H. Malenkovich, T. Nishimura, T. Okazaki, A. H. Honjo et al., PD-L2 is a second ligand for PD-1 and inhibits T cell activation, Nat. Immunol, vol.2, pp.261-268, 2001.

W. J. Lesterhuis, H. Steer, and R. A. Lake, PD-L2 is predominantly expressed by Th2 cells, Mol. Immunol, vol.49, pp.1-3, 2011.

N. Messal, N. Serriari, S. Pastor, J. A. Nunès, and D. Olive, PD-L2 is expressed on activated human T cells and regulates their function, Mol. Immunol, vol.48, pp.2214-2219, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00600726

A. L. Kinter, E. J. Godbout, J. P. Mcnally, I. Sereti, G. A. Roby et al., The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands, J. Immunol, vol.181, pp.6738-6746, 2008.

, June, vol.28, 2018.

X. Zhong, J. R. Tumang, W. Gao, C. Bai, and T. L. Rothstein, PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for VH11/VH12 and phosphatidylcholine binding, Eur. J. Immunol, vol.37, pp.2405-2410, 2007.

C. Guignant, A. Lepape, X. Huang, H. Kherouf, L. Denis et al., Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients, Crit. Care, vol.15, p.99, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00622817

S. Huber, R. Hoffmann, F. Muskens, and D. Voehringer, Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2, Blood, vol.116, pp.3311-3331, 2010.

!. #f#!,

P. Loke and J. P. Allison, PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells, Proc. Natl. Acad. Sci, vol.100, pp.5336-5341, 2003.

, C=5&0:/6# E61:*# <:FG@# 4:H5/)1%(# *:/H5&4(4# /5*# *:4+%:<:5/)(4# '10, vol.5, p.4

, # M%+5C)! Mq@q> #1W r1! G,4*! ?Gq@oLOi@ a1[ r1! V%,48&! $GNJoMU E 1! V%h(I'! BLGM # 1! j3C3)'! BjG\>OOcO "1Y 1! >3,5(4%! B>Ld>OOG a 1! J),4&)! V>jG a 1! ! j%-83+%! >d>OO@ a 1! J%3(4&)! ?oNs! VoMUL@t>N E 1! G,4*#

. !$clocuk, OBjoL$>M I 1!>(%4&!V>MtG k 1!B/,4'.4%&!?oLtGMOGM #1#F 1!`(8,)&*)!>JJ>L>@NNs #1#F r1!@'%P)

I. Irmb and U. Montpellier,

R. Arthritis and . Neuilly-sur-seine,

, Pathogenesis and Control of Chronic Infections

, Pediatric Orthopedic Surgery Unit

, FIRALIS SAS

, Centre d'Investigation Clinique

, Centre d'Investigation Clinique 411, INSERM

, Clinical department for osteoarticular diseases, p.4

N. I. Montgomery and H. R. Epps, Pediatric Septic Arthritis, Orthopedic Clinics of North America, vol.48, pp.209-216, 2017.

G. Dubnov-raz, O. Scheuerman, and G. Chodick, Invasive Kingella kingae infections in children: clinical and laboratory characteristics, Pediatrics, vol.122, pp.1305-1314, 2008.

A. Ferroni, A. Khoury, H. Dana, and C. , Prospective survey of acute osteoarticular infections in a French paediatric orthopedic surgery unit, Clinical Microbiology and Infection, vol.19, pp.822-830, 2013.

V. Kalinina-ayuso, N. Makhotkina, and M. Van-tent-hoeve, Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown, Survey of Ophthalmology, vol.59, pp.517-548, 2014.

B. Prakken, S. Albani, and A. Martini, Juvenile idiopathic arthritis, The Lancet, vol.377, pp.2138-2187, 2011.

G. Giancane, A. Alongi, and A. Ravelli, Update on the pathogenesis and treatment of juvenile idiopathic arthritis, Current opinion in rheumatology, vol.29, pp.523-532, 2017.

J. G. Harris, E. A. Kessler, and J. W. Verbsky, Update on the Treatment of Juvenile Idiopathic Arthritis, Current Allergy and Asthma Reports, vol.13, pp.337-383, 2013.

G. Dubnov-raz, O. Scheuerman, and G. Chodick, Invasive Kingella kingae infections in children: clinical and laboratory characteristics, Pediatrics, vol.122, pp.1305-1309, 2008.

M. Martinot, C. Sordet, and M. Soubrier, Diagnostic value of serum and synovial procalcitonin in acute arthritis: a prospective study of 42 patients, Clin Exp Rheumatol, vol.23, pp.303-313, 2005.

T. Honda, T. Uehara, and G. Matsumoto, Sugano M: Neutrophil left shift and white blood cell count as markers of bacterial infection, Clin Chim Acta, vol.457, pp.46-53, 2016.

I. Duroux-richard, C. Jorgensen, and F. Apparailly, What do microRNAs mean for rheumatoid arthritis?, Arthritis & Rheumatism, vol.64, pp.11-20, 2012.

T. Nakasa, S. Miyaki, and A. Okubo, Expression of microRNA-146 in rheumatoid arthritis synovial tissue, Arthritis & Rheumatism, vol.58, pp.1284-92, 2008.

S. Ono, S. Lam, and M. Nagahara, Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays, Journal of clinical medicine, vol.4, pp.1890-907, 2015.

J. Stanczyk, D. Pedrioli, and F. Brentano, Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis & Rheumatism, vol.58, pp.1001-1010, 2008.

!. #w,

R. Vicente, D. Noël, and Y. Pers, Deregulation and therapeutic potential of microRNAs in arthritic diseases, Nature Reviews Rheumatology, vol.12, pp.211-231, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01834238

D. Li, M. Duan, and Y. Feng, MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA, Molecular Immunology, vol.77, pp.205-217, 2016.

G. S. Schulert, N. Fall, and J. B. Harley, Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes, Arthritis & Rheumatology, vol.68, pp.2300-2313, 2016.

J. Sun, M. Feng, and F. Wu, Plasma miR-26a as a Diagnostic Biomarker Regulates Cytokine Expression in Systemic Juvenile Idiopathic Arthritis, The Journal of rheumatology, vol.43, pp.1607-1621, 2016.

Y. Kamiya, J. Kawada, and Y. Kawano, Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis, Clinical Rheumatology, vol.34, pp.1705-1717, 2015.

X. Ma, F. Wu, and L. Xin, Differential plasma microRNAs expression in juvenile idiopathic arthritis, Modern Rheumatology, vol.26, pp.1-9, 2015.

S. Singh, G. Rai, and A. Aggarwal, Association of microRNA-146a and its target gene IRAK1 polymorphism with enthesitis related arthritis category of juvenile idiopathic arthritis, Rheumatology International, vol.34, pp.1395-400, 2014.

C. Aupiais, R. Basmaci, and B. Ilharreborde, Arthritis in children: comparison of clinical and biological characteristics of septic arthritis and juvenile idiopathic arthritis, Archives of disease in childhood, vol.102, pp.316-338, 2017.

R. Basmaci, B. Ilharreborde, and S. Bonacorsi, Septic arthritis in children with normal initial C-reactive protein: clinical and biological features, Arch Pediatr, vol.21, pp.1195-1204, 2014.

K. Murata, H. Yoshitomi, and S. Tanida, Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis, Arthritis Research & Therapy, vol.12, p.86, 2010.

C. C. Pritchard, E. Kroh, and B. Wood, Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies, Cancer prevention research, vol.5, pp.492-499, 2012.

M. Monleau, S. Bonnel, and T. Gostan, Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells, BMC Genomics, vol.15, p.395, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02106442

Y. Kim, J. Yeo, and B. Kim, Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells, Mol Cell, vol.46, pp.893-898, 2012.

J. Rice, H. Roberts, and J. Burton, Assay reproducibility in clinical studies of plasma miRNA, PLoS ONE, vol.10, p.121948, 2015.

P. Mestdagh, N. Hartmann, and L. Baeriswyl, Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study, Nat Methods, vol.11, pp.809-824, 2014.

J. Chen, G. Papp, and S. Póliska, MicroRNA expression profiles identify diseasespecific alterations in systemic lupus erythematosus and primary Sjögren's syndrome, PLOS ONE, vol.12, p.174585, 2017.

R. Hezova, O. Slaby, and P. Faltejskova, microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients, Cellular Immunology, vol.260, pp.70-74, 2010.

T. Niimoto, T. Nakasa, and M. Ishikawa, MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients, BMC Musculoskeletal Disorders, vol.11, p.209, 2010.

K. M. Pauley and S. Cha, miRNA-146a in rheumatoid arthritis: a new therapeutic strategy, Immunotherapy, vol.3, pp.829-860, 2011.

A. V. Churov, E. K. Oleinik, and M. Knip, MicroRNAs in rheumatoid arthritis: Altered expression and diagnostic potential, Autoimmunity Reviews, vol.14, pp.1029-1066, 2015.

A. Lenert and D. W. Fardo, Detecting novel micro RNAs in rheumatoid arthritis with genebased association testing, Clinical and experimental rheumatology, vol.35, pp.586-92, 2017.

D. Malik, A. Sharma, and A. Raina, Deregulated Blood Cellular miR-2909 RNomics Observed in Rheumatoid Arthritis Subjects, Archives of Medicine, vol.7, pp.1-6, 2015.

D. Kaul, M. Sasikala, and R. A. , Regulatory role of miR-2909 in cell-mediated immune response, Cell Biochemistry and Function, vol.30, pp.500-504, 2012.

K. D. Taganov, M. P. Boldin, and K. Chang, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc Natl Acad Sci, vol.103, pp.12481-12487, 2006.

I. Faraoni, F. R. Antonetti, and J. Cardone, miR-155 gene: a typical multifunctional microRNA, Biochim Biophys Acta, vol.1792, pp.497-505, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00488806

L. Wang, Y. Qin, and L. Tong, MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region, Antiviral Research, vol.93, pp.270-279, 2012.

C. Vasilescu, S. Rossi, and M. Shimizu, MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis, PLoS ONE, vol.4, p.7405, 2009.

Q. Li, Y. Fang, and P. Zhu, Burkholderia pseudomallei survival in lung epithelial cells benefits from miRNA-mediated suppression of ATG10, Autophagy, vol.11, pp.1293-307, 2015.

S. C. Wong, R. Dobie, and M. A. Altowati, Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions, Endocrine Reviews, vol.37, pp.62-110, 2016.

V. Wiegering, H. J. Girschick, and H. Morbach, B-cell pathology in juvenile idiopathic arthritis, Arthritis, vol.2010, pp.1-6, 2010.

M. G. Barnes, A. A. Grom, and S. D. Thompson, Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis, Arthritis & Rheumatism, vol.60, pp.2102-2114, 2009.

B. Koca, S. Sahin, and A. Adrovic, Cardiac involvement in juvenile idiopathic arthritis, Rheumatology International, vol.37, pp.137-179, 2017.

J. Nicolau, T. Lequerré, and H. Bacquet, Rheumatoid arthritis, insulin resistance, and :@A!B(-#C#D!'6,!*,jUt!v/8()!.,%&'*,49.8-)!-4LM>!RpU>T!S4, vol.3

+. %. )&apos;ta!o%-, 9%,)+!%**, vol.8, p.78

!. and !. %&amp;+!-#e!-?, ! 87! 'I&8=4%(! 7(34+! '%-9, p.4

, &3*()%')! 9,8.)*.48&! %''%I! %&+! 9, vol.8, p.78

!. P%, , vol.78

. 4&amp;c!j, &U%:!RVoaaWO1!MGd1!G=,I1!`,%&*)T!)&<I-)A!`8,!)%*/!'%-9

!. +muj&apos;!-r#f!-&amp;vt!-rmgd1 and !. Mf, OT1! D! ?(! 87! o&)U%:! JBL! tB! d377),! Eu! RdkFWaO1! MGd1! G=,I1!`,%&*)T1! a! ?(! 87!`8,v%,+! %&+! L)=),')! J,4-)

O. %. ;-+!-8&amp;!-&gt;d@!-w&quot;wf!, 9%,%.48&! %&+! #W! ?(! 87! jWFA! JBL! '.)9! v%'! 9, vol.9

!. #f!-4&amp;a, !3'4&C!./)!78((8v4&C!*I*(4&C!9, vol.874

. *!-b5!-8, /)! (4P,%,I1! >C)&.*83,! >VJ3,)! uJ! P)%+'!, vol.9

. R&gt;dayyf1!-d)*s-%&amp;*, 1! \4(()94&.)1!`,%&*)T! v),)! 3')+A!`8,! )%*/! '%-9, ! a"AE! ?(! 87! >VJ3,)! uJ!, vol.83

. %+&apos;!%,

!. +!78, %&+!./)&!9(%*)+!8&!./)!-%C&).4*!'.%&+A!>7.),!W! -4&3.)'!.8!')9%,%.)!P)%+'1!./)!*()%,)+!'8(3.48&!4'!*%, p.8

. %+&apos;!-%,)!-v%&apos;/)+!-w!,

*. %&amp;+!-;-9%, %. Jbl!9, 8. *. &apos;!%&amp;+!p)%+&apos;a, /. J#3#&apos;0+, !. 3+&amp; et al., 1! i%9%!d48'I'.)-'!:JBL!i4.!Rii[YW[1!B(4&4'*4)&*)1!M%&.),)1!, vol.8

!. %&amp;+% and +. ,

!. , %. , I. 3&amp;!-8&amp;!-%!-&gt;d@, and !. Jl@ov!, ! %.! #z#FFFFTA! U/)! '%-9

. !*i*(, !87!kEnB!78,!aF!')*!%&+!DEnB!78

+. Pi!%!+4, , vol.8, pp.98-102

. %-9, *8&! 87! MJJ! v4./! P%,*8+)! *, vol.8, p.98

*. 8&amp;*)&amp; and %. , , vol.87

-. +. &amp;&amp;, (. 8+, and -. G%*/!-&apos;%-, ! 4'! 988()+! 4&! 8,+),! .8! C)&),%.)! %! 988, vol.988

!. %&amp;*)t!%.!wf!9v!v%-;-9%, ). %&amp;+!e&quot;f!?-;-+!(4p, %. , I. !. Wf!9v!-v%-;-!-s4, C. %&amp;+!-;-&amp;*)+a et al., ! -4H! v4./! aF! ?(! 87! WF! 9V! J/4u! %&+! (8%+)+! 4&.8! M)H.O):! j4C/! 83, -4&%!M)H.O):!9(%.78,-!%&+!9,8*)'')+!PI!./)!jUt!J%,'),!'87.v%,)A, K&'0/.+L/3+&,*, d)78,)! ./)! &8,-%(4<%.48&! 87! ./)! +%.%1! %! &)C%.4=)! *8&.,8(! R>MUT! xB! 4'! 9, vol.9

). %cc)+!%&apos;!xb!7%4-;-!%&amp;+!% and ). , %&%(I'4'A!U/)!&8,-%(4<%.48&!4'!*8&, !8&!k! '.)9'g!#T!L)-8=%(!87!./)!P%*SC,83&+!87!./)!'%-9

!. and !. V4,

, B8-93.%.48&! 87! ./)! -)+4%&! 87! )%*/! '%-9

, &5#/5*#[1/5):E:+/):&5#!

=. and &. %&amp;&apos;*, 48&!87!./)!-4LM>'!%&+!9, vol.78

&. !-3&apos;4&amp;c!-u%:v%&amp;?!-v4*, &. 8lm&gt;!-l)=), . !. %&amp;&apos;*,49.48&amp;!-s4, and . %&amp;+!-u%:v%&amp;?!-j, ! V4H1!, vol.78

). *%*i!-87!--4lm&gt;!-;-&amp;.%,i!`4c3 and . Oata, 3%&.474*%.48&! /%=)! P))&! =%(4+%.)+! R8&(4&)! '399

. 9% and . 4&amp;4&lt;)+!-.3p, ! 78,! *8&'.,%4&

. +!-&apos;%-9, , vol.7

, C34+)(4&)'! 78,! -4&4-3-! 4&78,-%.48&! 78,! ./)! 93P(4*%.48&! 87! LUK:JBL! )H9),4-)&.'! l#mA! U/)! U%:V%&!

%. *. 48&amp;&apos;!-v, , vol.78

!. ,

, KE91! /'%K-4LK#EEKE91! /'%K-4LKaakKa91! /'%K-4LKa

, !8&!%!\44>!" UV !'I'.)-!3'4&C!U%:V%&?!`%'.!>+=%&*)+!V%'.),!V4H!RU, vol.78

, +A!U8!+8!'81!, vol.78

$. %. , %&%(I<)+!3'4&C!J),')3'!'87.v%,)!lWmA!U/)!+477),)&.4%((I!)H9,)'')+!9,8P)K'), p.74

, I!9%,%-).),'!3'4&C!%!'4C&%

, &.!-4LM>'A!`%(')!$4'*8=),I!L%.)!R`$LT!v%'!+).),-4&)+!v4, vol.9

!. R78(+!-*/%&amp;c)!-r`bt!-|kw!-%&amp;+!-}!-fwt1!-8,!-(8cw!-r`b!-|kw!-%&amp;+!-}!, ! 4+)&.47I! +477),)&*)'! 87! -4LM>!

, M)1*(# *(4# <9+/5:4<(4# :<36:[194# */54# 6/# 3,=4:&3/),&6&H:(#*(#6?@AB# ! B5)%&*1+, p.5

. !-n;,

, 23=5&4()! 4+489%./4:3)! R>?@T! )'.! 3&! C,839)! /5.5,8C0&)! +)! ,/3-%.4'-)'! 4&7, vol.84

*. , !)&7%&.'!+)!-84&'!+), vol.8

!. Wf!-4&amp;+4=4+3&apos;!-&apos;3, !. #ff!-fff!-9%, !. %&amp;!-).!-)&apos;.!-*%, and %. ,

, D! ')-%4&)'! )&! (;%P')&*)! +)! .,%4.)-)&.'! RJ,%SS)&! ).! %(A1! WF##TA! O)9.! '83'K.I9)'! '8&.! 4+)&.4745'! )&! 78&*.48&! +3! &8-P,)! +, vol.9

!. , .. %4&amp;-;-!-+3, and %. !-(-;-!ef]!+, ! -%&47)'.%.48&'! )H.,%K%, vol.4

!. %. , 4&.)!+;3&)!6![!%,.4*3(%.48&'!%3!*83, vol.9

, ! +5=)(899)-)&.! +;3&)! 3=54.)! RJ,%SS)&! ), pp.8-9

, !P%')'!9/I'489%./8(8C4:3)'!+)! (^>?@!,)'.)&.!)&*8,)!-%(!*8-9,4')'A!J%, )!).!+3!7%4P()!&8-P,)!+)!9%.4)&.'!.83*/5'1!(

, .5!4&&5)!).!%+%9.%.4=)!)'.!8P'),=5!+%&'!(^>?@!R+)!?%C),!).!%(A1!, pp.4-7

!. Wff&quot;x!-v%*%3p%&apos;!-).!-%(a1!-wffkx and %. V3, ! %(A1! #kkDTA! N)'! -8&8*I, vol.84

, ! '3,! P%')! +)! (;)H9,)''48&! +)'! -%,:3)3,'! -)-P,%&%4

*. I. ,

, ! -8&8*I.)'! *(%, vol.4

!. , ! *4,*3(%&.'A! @('! )H9,4-)&.! +)! 7%Z8&! 4-98, %&.)! BBLW1! ()! ,5*)9, vol.3

, ! */4-48S4&)! VBJ#1! '8&.! '95*4%(4'5'! +%&'! (%! ,598&')! %&.4KP%*.5,4)&&)! ).! .,0'! )774*%*)'! 983

. /%c8*i, !&8&!*(%''4:3)'!'8&.!:3%&.!6!)3H!*8&'4+5,5'!*, vol.8

+. , !?! +)! (%! 9%,84! =%'*3(%4,)! Rp8&C! ).! %(A1! WF#WTA! N)3,! -8P4(4.5! )'.! +59)&+%&.)! +)!, vol.834

!. ,

, %+/5'48&! N`>K#! R(I-9/8*I.)! 73&*.48&K%''8*4%

%. Wf#wta!-b)&apos;!-*, ! ,)9,5')&.)&.! "]! +)'! -8&8*I.)'! '%&C34&'1! )(()'! '8&

, 98&+)&.! 6! E]! +)'! -8&8*I.)'! +3! '%&C! 98

-. ). 4&amp; and ). , *)(34!+)'!-8&8*I.)'!*(%''4:3)'!).!+)'!&8&!*(%, vol.4

&. %. 48&amp;!-%&amp;-;-!@nk#!).!@nkd!, 4C5&4:3)! ).! 9,8+34')&.! +)'! :3%&.4.5'! 4-98, LoO! ).! %3.,)'! -5+4%.)3,'!4&7, vol.84

!. %. 48&amp;!-+)!-(%!, )&*)! +)'! -8&8*I.)'! 4&, 5+4%4,)'! %! 5.5! +5*,4.)! +%&'! +)'! *%'! +)

. &amp;7%&amp;.&apos;!-%..)4&amp;.&apos;!-+;&gt;?@!, ! +8&&5)'! '3CC0,)&.! :3)! ()'! -8&8*I.)'! 4&, X! j)&, vol.4, issue.45

A. and !. %4, 1!+)!&8-P,)3')'!5.3+)'!-8&.,)&.!:3)!(;)H9,)''48&!+, vol.84

, %3! +5=)(899)-)&.! +)! 9%./8(8C4)'! %, vol.4

. I!-).!-%(a1!-wffyta!-g&amp;!, 1! *)'! 9, vol.77

, (;)H9,)''48&! +)!

). &amp;8-p and . 3h!c0&amp;)&apos;!).!+, P%.48&'!%3!&4=)%3!+)!()3,!)H9,)''48&!8&.!3&!4-9%*.!'4C&474*%.47!'3,!(%! ,598&')! 4&7, vol.84, pp.4-9

!. and ). 83=5)!-+%&amp;&apos;!-3&amp;!-no!-*8&amp;, 4&+4:3)&.! :3)! (;)H9,)''48&! +)! -4LK#EF! +%&'! ()! NO! +;)&7%&, vol.84

A. and !. %4, 1!+)'!5.3+)'!-8&.,)&.!:3;4(!)H4'.)!3&)!*8, vol.3

!. , Q. +%&amp;&apos;!(%!c5&amp;5, and %. 48&amp;!+)&apos;!-8&amp;8*i, !4&.),-5+4%4,)'!).!&8&!*(%, vol.4

. N&gt;nk!-r, &K)()=)&K.,%&'(8*%.48&KaT! :34! *8+)! 983,! 3&)! +48HIC5&%')! (4%&.! ).! +5-5

&. Ro, !).!%(A1!WF#YTA!$)!, vol.9, pp.4-8

!. +%&amp;, !(%!9/I'489%./8(8C4)!+)!(;>?@!

, Q/)9%:(64#()#<9),&*(4#

. !-$/, )4#()#*&55, p.54

, ! )&7%&.'! +)! [! 6! #E! %&'! 8&.! 5.5! 4&*(3'! +%&'! *)

B. , ! j8'94.%(4),! c&4=),'4.%4,)! RBjcT! +)! V8&.9

, ! +4%C&8'.4*! +)! (;>?@A! N)'! )&7%&.'! %..)4&.'! +;>?@! '

!. %i%&amp;, %4.)-)&.'! R'.5,8h+)'1! P48./5,%94)'1! -5+4*%-)&.'! %&.4,/3-%.4'-%3HT! %3! *83,'!+3!-84'!9, vol.9

, ! 9%,)&.'! 83! .3.)3,'! %! 5.5! 8P.)&3! 983,! .83'! ()'! 9%.4)&.'1! *8&78,-5-)&.! %3H! 9,8*5+3

8. %99 and !. Rwf#, ! B8-4.5! +)! J,8.)*.48&! +)'! J),'8&&)'! O3+! V5+4, 0=)-)&.'!+)!'%&C!).!+)!NO!5.%4)&.!*8(()*.5'!+%&'!+)'!.3P)'!, vol.9

, !+)!'%&C!+)!+8&&)3,'!'%4&'!8&, vol.9

!. O%&amp;c!-rg`ot!-+)!-v8&amp;, ! ).! *, vol.8, issue.9

. !*), !-8&8&3*(5%4,)'!+3!'%&C!95,49/5,4:3)!RJdVBT!+)'!+8&&)3,'!'%4&'!8&

, */&4:3)'! +)! '59%,%.48&! 3.4(4'%&.! 3&! C,%+4)&.! +)! +)&'4.5!`4*, vol.8

*. I. )&apos;!-b$#, ! 8&.! )&'34.)! 5.5! '59%,5'! +)'! %3.,)'! .I9)'! *)

. 3&amp;!-s4.!-+-;-&amp;.!--%c&amp;5, :3)! %=)*! +)'! P4, vol.4

. !. %&amp;,

, 3+)! +)! (;)77).! +3! NO! '3,! (, ! *, vol.5, issue.3

!. ,

. B$#[-f-!-r#!-h!-#f-d-!-*,

, NO! %=%4)&.! 5.5! *)&.,473C5'! #F! -4&3, vol.9

, *8&'),=5'!6!KYFnBA!c&!784'!+5*8&C)(5'1!4('!5.%4)&.!+4(35'!#!g!aF!+%&'!(

, !6!a"nB!%=)*!(, vol.3, pp.8-8

N. 48&amp;&apos;!+)!, %&'7)*.48&!5.%4)&.!)77)*.35)'!%=)*!+)'!-8&8*I

. +3!, 3C)&)! j$! RJ,8-)C%T! %4&'4! :3

!. J83 and . %&amp;%(i&apos;)!+)&apos;!-8&amp;8*i, !+3!'%&C!).!+3!NO!+)'!9%.4)&.'!%..)4&.'!+;>?@1!3&)!'5()*.48&!+)'!*)

$. &gt;j@-k-!-b$[e-f-!-%!, ! )77)*.35)A! N)'! C,%&3(8*I

R. Rb$a1!b$#k!).!b$edt!8&amp;-;-!-%, !).!)H*(3'!(8,'!+)'!%&%(I')'!4&78, 84'!'83'K 9893(%.48&'!+)!-8&8*I.)'!8&.!)&'34.)!5.5!4+)&.4745)'!)&!78&*.48&!+)'!-%, vol.4, p.35

, %&.4*8,9'! '34=%&.! 8&.! 5.5! 3.4(4'5'!g! %&.4KjN>K$LK>JBKBI"! Rd)*S-%&! B83

. B$#dkd\-;-&amp;*)&apos;ta!-n, FF1! %&.4KB$#[Kd\DEF! Rd$! d48'*4), vol.38

%. , 34'4.48&! +)! *)'! *)

. &amp;*)&apos;t!).!(, !%&%(I')'!8&.!5.5!,5%(4'5)'!%=)*!()'!(8C4*4)('!$@\>!)

%. N%!*%, 5,4'%.48&!9/5&8.I94:3)!+)'!-8&8*I.)'!B$#[ f !
URL : https://hal.archives-ouvertes.fr/hal-00120582

, '5)!6!(%!'34.)!+;3&)!)H*(3'48&!+)'!*)

, ?!`4H%P()! \4%P4(4.I! i4.1! d48N)C)&+TA! N)! -%,:3%C)! +)'! ,5*), p.9

!. %=)*!(, !%&.4*8,9'!'34=%&

. %/+, #F, p.8

*. 3p)!rx@&gt;tgmta, !. N)&apos;!.%3h!+;)h9, and ). , !-4>LM'!).!>LM!-)''%C),'!R>LM-T!8&.!5.5!:3%&.4745'!6! (%! '34.)! +;3&)! .,%&'*,49.48&! 4&=),')! %=)*! 3&! S4.! ?!U%:V%&! -4*,8LM>! L)=),')! U

&. ?!j4c/!b%9%*4.i!*$m&gt;!l)=) and . %&amp;&apos;*, 48&!?!R>99(4)+!d48'I', 1!d48KL%+TA!c&)!:JBL!%!)&'34.)

!. U%, V%&!c&4=),'%(!V%'.),!-4H!?!%4&'4!:3)!+)'!%-8,*)'!'95, vol.474

!. @@pg!r&gt;99, )+!d48'I'.)-'T!RL8.8,Kt)&)Kx1!x@>tGMTA!N;)H9

. N%!78, 4*3(%4,)!+)!(;>?@!)'.!()!'83'K.I9)!()!9(3'!,59%&+3!)&!G3,89)!RJ,%SS)&!)

. %c4,

, ! /5.5,8C0&)1! 983

. A!-$, ! +)! (;4--3&4.5! 4&&5)! *8--)! ()'! -8&8*I, ! 5.3+)'! 8&.! -8&.,5! :3)! ()'! *)

!. and Q. , ! -%2)3,! +%&'! ()! *)..)! 9%./8(8C4)! R+)! ?%C),! ), vol.283

. %. &apos;!-+;b.-;-&amp; and . 48&amp;!-%&amp;, !*I.8S4&)'!:3;4('!9,8+34')&.A!$%&'!&8.,)!5.3+)1!&83'!&83'! '8--)'!4&, WFFkTA! G&! )77).1! )&! 9, vol.84, pp.4-9

, !+)!-8&8*I.)'!+5*,4.)'!+%&'!(%!(4, 40,)!784'!3&)!%**3-3(%.48&!'4C&474*%.4=)!+)!-8&8*I.)'!4&

, &3)'!%3!&4=)%3!+3!(4:34+)!'I&8=4%(!+)!9%.4)&.'!%I%&.!3&)!>?@!(45)!6!

!. and ). &amp;78, *)! (;/I98./0')! :3)! *)! '83'K.I9)! +)! -8&8*I.)'! 283)! 3&! ,Q()! 9%

%. C5&amp;5 and ?. (a!-t, , vol.5

, %=8&'! 93! 5.3+4),! +)'! *8&*)&.,%.48&'! )&! *I.8S4&)'! +3! '5,3-! ).! +3! (4:34+)! '

!. @nky!-+%&amp;&apos;!-(, ! (4:34+)! 'I&8=4%(! 983=%&.! )H9(4:3),! ()! ,)*,3.)-)&.! +)'! -8&8*I.)'! %3! ')4&! +

, !)&!:3%&, vol.9

, +%&'!()!(4:34+)!'I&8=4%(!*8-9%,5!%3!'%&C!95

*. I. 8s4&amp;-;-3=)&amp;.!b, !-8&8*I.)'!*8--)!()!-8&.,)!()'!5.3+)'!+)!O%H)&%!, 8+34.)'!9%,!(

. &lt;!-+, ! 9%.4)&.'! >?@! RO%H)&%! ).! %(A1! WFFETA! B)'! *I.8S4&)'! *8&, pp.4-7

, %3!')4&!+)!(;%,.4*3(%.48&!+)!*)'!9%.4)&.'!%, vol.84

. !+)!-8&amp;8*i.)&apos;!b$#, +8&&)3,'!'%4&'!%=)*!+3!(4:34+)!'I&8=4%(!+)!9%.4)&.'!>?@1!&83'!%=8&'! 8P'),=5!:3)!()!(4:34+)!'I&8=4%(!*8&.4)&.!+)'!, vol.5

, )!)&!(4)&!%=)*!+)'!5.3+)'!:34!-8&.,)&.!:3)!()'!-8&8*I.)'!4&.),-5+4%4,)'! '8&.! 4-9

!. Wf#wx!q%v%+%!).!%(a1!wf##ta!b, !78&*.48&'!983=%&.!b.,)!%''8*45

. &gt;74&amp;!-+,

, 4+)&.474),! 3&! 5(5-)&.! +3! (4:34+)! 'I&8=4%(! 983=%&.! )H9, vol.4, p.77

*. I. ;-!&amp;83&apos;!&amp;83, !4&.5,)''5'!6!-4LK#EFA!G&!)77).1!+)!9, 5*5+)&.'!,5'3(.%.'!8P.)&3'!+%&'! &8.,)!5:349)!-8&.,)&.!:3)!-4LK#EF!)'.!78,.)-)&.!)H9,4-5!+%&'!(

, ! 8(4C8%,.4*3(%4,)! *8-9%,5! 6! *)3H! %I%&.! 3&)! %,./,4.)! ')9, vol.4

&. , 48&!+)'!-8&8*I.)'!*(%''4:3)'!)&!-8&8*I, !(4C&5)'!(I-9/8h+)'!).!-I5(8h+)'!).!%!5.5!, vol.5

!. Ro, ! ).! %(A1! WF#YTA! B)'! +8&&5)'! '8&, ! %=)*! &8'! 8P'),=%.48&'! :34! -8&.,)&.! 3&)! )H9,)''48&!, pp.4-98

*. I. , ! 4&, 5+4%4,)'A! U83.! *8--)! *)..)! 5.3+)! ,5*)--)&.! 93P(45)1! &83'! %=8&'! 8P'),=5! 3&)!

). +4-4&amp;3.48&amp;!+3!&amp;8-p, !4&.),-5+4%4,)'!'34.)!6!(%!&)3.,%(4'%.48&!+)!(;)H9,)''48&!+)!-4LK

. #efa!-u83-;-!-*8&amp; and ). %4, ! +)! O)(4-8C(3Kd3).! ), vol.5

. &amp;*)&apos;!, %3! &4=)%3! +)'! +3,5)'! ).! +)'! .)*/&4:3)'! +)! .,%&'7)*.48&! %99, vol.3, p.35

, !/5-%.898h5.4:3)'!B$a, *, vol.3

, M8'! 5.3+)'! 8&.! 9),-4'! +;4+)&.474),! 3&! C0&)! +8&.! (;)H9,)''48&! )'.! 98.)&.4)(()-)&.! ,5C3(5)! 9%

!. #ef1!6!&apos;%=84, . @@pga!&gt;!&amp;8, and . )!*8&amp;&amp;%4, %&*)1!%3*3&)!+8&&5)!&;)

!. , %&'7)*.48&! +3! -4LK#EF! '3,! (;)H9,)''48&! +)! BBLW! %3! &4=)%3! +)'! -8&8*I.)'A! BBLW!

*. 8&amp;&amp;3!983, :35!+%&'!()!,)*,3.)-)&.!+)'!-8&8*I.)'!'3,!()!'4.)!4&7, vol.84, pp.4-9

, %3!&4=)%3!+)'!-8&8*I.)'!*(%''4:3)'!'8, vol.3

, !+4-4&3)!%3!&4=)%3!+)'!-8&8*I.)'!4&.),-5+4%4,)'!).!+)'!&8&!*(%''4

, %3H! 5()=5'! 8&.! 5.5! +5.)*.5'! +%&'! ()! (4:34+)! 'I&8=4%(! +)'! )&7%&.'! %I%&.! 3&)! >?@! 8(4C8%

*. 8&amp;*)&amp; and %. , %&.)'!+)!-4LK#EF!%3!&4=)%3!+)'!%,.4*3(%.48&'!+;)&7%&.'!>?@!983,%4)&.!+4-4&3, pp.4-98

*. %. , 4=)-)&.!(;)H9,)''48&!+)!BBLW!%3!&4=)%3!+)'!-8&8*I.)'!9

!. , 5. , and ). !. , ! -4C,%.48&A! c&)! 7%4P()! )H9,)''48&! +)! BBLW! 983, vol.3

+. , ! %3! ')4&! +)! (;%,.4*3(%.48&! +)'! )&7%&, 4&.'! +;>?@! 8(4C8%,.4*3(%4,)! 8?! *)'! *)

, 8+34'%&.! +)'! :3%&.4.5'!, vol.9, p.8

, A! G&! *8&*(3'48&1! (, ! +8&&5)'! C5&5,5)'! 9%,! &8.,)! 5:349)! -8&, vol.84

-. ). 4&amp; and ). +%&amp;&apos;!(, !%,.4*3(%.48&'!+)'!9%.4)&.'!%I%&.!3&)!>?@!8(4C8%, vol.4

. &amp;!-9%,

!. 9%, !. , and ). , %&.)! +)! -4LK#EF! +%&'! ()! (4:34+)! 'I&8=4%(A! G&! 9, p.9

, !8,C%&)'!(I-9/8h+)'A!>74&!+)!983,'34=)!(;5.3+)! '3,! (, *%.48&! +3! -4LK#EF! +%&'! (%! 9/I'489%./8(8C4)! +)! (;>?@1! 4(! )'.! &5*)''%4,)! +)! =%(4+),! (%! (4%4'8&! ! #Da!, vol.4

). *. +4 and . )!-+)!-*)!--4&gt;lm!-%3!-&amp;4=)%3!-+)!-(%!-&apos;, 5:3)&*)! *4P()! +)! (;>LM-! +)! @@PG! ).! +;%&%(I'),! (;)H9,)''48&! C5&4:3)!).!9,8.54:3)!+)!BBLW!%3!&4=)%3!+)'!-8&8*I

%. +;&gt;?@!-;-!-*%, A! $)! 9(3'1! 4(! '),%4.! 4&.5,)''%&.! +;)77)*.3),! 3&)! 3&), vol.4

. %. +)&apos;!-8&amp;8*i.)&apos;!.-;-&amp; and . 48&amp;!%&amp;, %&'7)*.5'!%74&!+;5.3+4),!(, vol.4

!. +%&amp;&apos;!(%!*%9%*, !-8&8*I.)'!6!4&+34,)!3&)!%*.4=%.48&!).!3&)!, vol.9

, F9E9%(5+(4#P:P6:&H%

!. %1!la1!%&amp;+!&gt;cc% and ;. @&amp;, L/)3-A!FI1!##wWFA! t%3,1!JA1!VI(, +4%.)!-8&8*I.)'!%,)!4&*,)%')+!4&!

. +!%-;-!%!*%, C8,I!87!23=)&4()!4+489%./4*!%

!. &gt;a1!@&amp;b, ;. B%, and . =%, 81!UA1!B83.81!VA1!>&+,%+)1!OEA1!J)+,)4,81!OA1!N%,%&2)4,%1!JA1!V8,C%+81! ?AVA1!J%4'1!VANA1!+%!O4(=%1!?A>AJA1!)

!. , !. %&amp;+!j, and . %ss)&amp;1!da?a!-rwff, ?%C),1!pA1!j899)&,)42'1!GAJA>AjA1!p3(77,%%.1!MAVA1!p)++),P3,&1!NALA1!i34'1, p.4

!. We, YwWEYDA!

, N431!BAKjA1!O3&1!sA1!N41!?A1!t8&C1!sA1!U4%&1!iAUA1!G=%&'1!NAJA1!V8,''1!JABA1!`,)+,4*S1!UApA1!O%P%1!MA?A1!%&+!

. B/)&amp;1!?a!rwf#eta!g&amp;+8, /)(4%(!-4*,8LM>K#EF!4'!%&!4&.,4&'4*!'399, vol.8, p.9

!. Ga$a!rwffkta and !. , V%*%3P%'1!BA1!MC3I)&1!iA1!V4(82)=4*1!$A1!J%,S1!?ANA1!%&+!V)((4&'1, p.94

, 4&81!>A1!d3)&+4%1!JA1!V%,.4&KV%(81!>A1!>(2%-%1!JA1!L%-4,)<1!LA1!%&+!B%

!. B$#[fb$#df, 84&7(%--%.8,I!%&+!9, %I1!iA?A1!N3I, vol.9, p.1

. Va!rwf#fta!v4*, D%!)H9,)'')'!4&!4&.),()3S4&K#"!9

, A!dVB!V3'*3(8'S)

A. and +. Wfka,

. -4lk#, D%!)H9,)''48&!4&!9

, I1!LAGA1!O83./v88+1!UALA1!V%&&),'1!JA1!d%3-1!?A1!t(%''1!$AMA1!t8(+)&P)

*. 8&amp;+!,

J. , %. V%, and .. 4. &gt;a!rwf##ta!, 3=)&4()!4+489%./4*!%

!. Uama1!d3-;-%, ;. +1!$aba1!%&amp;+!d%, and . Ta!@b&gt;vk#g!@, =%.)+!*8&*)&.,%.48&'!, vol.878, pp.87-95

*. I. 8s4&amp;, !4&!'I&8=4%(!7(34+!87!*/4(+,)&!v4

. *!%,

!. V%, !LAKLA1!, p.1

, O>tG!)=4+)&*)!78,!B$#[ffB$#Df!-8&8*I.)'!%'!%!./4,+!-8&8*I.)!'3P'), p.88

, 23=5&4()! 4+489%./4:3)! R>?@T! )

. !*/, , vol.84

). &amp;+ and . !(-;-!+5=, !-5*%&4, p.899

, 8(8C4)! )&! )&! -;

, 4&.5,)''%&.! %3H! '83'K9893(%.48&'! +)! -8&8*I.)'! ).! +)! $B'!

. %3h!-9-;-4&amp;.&apos;!+;&gt;?@a!b, !+;)H9,)''48&!+)'!-4>LM'!+3!'%&C!95,49/5,4:3)!).!+3!NO!+)'!)&7%&, vol.874

). &. +4775 and . &apos;!-%, )3,'!*)((3(%4,)'!).!-8(5*3(%4

, !+5=)(899)-)&.!+)'!-%(%+4, pp.34-34

, &5#3,95&)=3

!. J83, 40,)!9%,.4)!+)!-8&!9, vol.9

. %4!, , vol.4, p.3

!. 9%, 4)&.'! %..)4&.'! +;>?@! ), ! +

. &gt;oa!-n, ! )&7%&.'! +3! C,839)! >O! %=%4)&.! .83'! 6! 98

*. and %. *. , !+3!'I'.0-)!4--3&4, 48&!9/5&8.I94:3)!+)!+4775,)&.)'!*)

, 40,)!784'!+)'!'83'K9893(%.48&'!9, vol.9

. !+;,

!. 7%z8&amp;!-c5&amp;5 and %. , ! -%,:3)3,'! +)! '3,7%*)! %&%(I'5'! 983, vol.3

, =4'5)1! ()! NO! )'.! ()! 7(34+)! P48(8C4:3)! :34! +4'*,4-4&)! ()! -4)3H!

!. &gt;oa!-$%&amp;&apos;!-(-;-!-+)!-&amp;8-p-;-!-no!-9%, %. , and .. !. %3!-&apos;%&amp;ca!-n8, ! ,)'')-P(%&*)'! )&.,)! >?@! ).! >OA! O)3()! (;>O! -8&.,)! 3&! )&,4*, ! a! '83'K9893(%.48&'! +)! -8&8*I.)'! '8&.! %&%(I'5)'1! (, vol.5, p.5

. +%&amp;&apos;!-(-;-!-no!-+, ! -8&8*I, ! 9%.4)&.'! >O! :3)! +%&'! *)(34! +)'! >?@A! $%&'! ()! '%&C1! ')3('! (

. !-*%&apos;!-+, , pp.4-98

!. &gt;o!-9%, %. , and .. !. %3h!-&gt;?@a!-$%&amp;&apos;!-+)!,

. &amp;8-p, !-%(%+4)'1!%3''4!P4)&!+;8,4C4&)!4&7)*.4)3')!:3, vol.4

). &amp;8-p, !B$#D f !)'.!%3C-)&.5!+%&'!()!'%&CA!B;)'.!()!*%'!, vol.983

&. Ros and . &lt;i&amp;&apos;s%!, ! +)'! &83=)%3K&5'! %I%&.! 3&! */8*! ')9

&. %. 48&amp;!+3!&amp;8-p and ). , !4&.),-5+4%4,)'!).!&8&!*(%, vol.4

, */)<! ()'! )&7%&.'!9,5')&.%&.!.83'!(, vol.4, pp.4-98

, !+3!'%&C!&)!-8&.,%4.!9%'!+), vol.9

. P%*.-;-&amp;&amp;)a!n)&apos;!-8&amp;8*i, !4&.),-5+4%4,)'!5.%4)&.!:3%&.!6!)3H!9(3'!9,5')&98,.%&.! +)! -8&8*I.)'! 4&, vol.5

!. , !:3)!()'!&8&!*(%

*. %c)&apos;!-+)!--8&amp;8*i, ! 4&.),-5+4%4,)'! ).! &8&! *(%''4:3)'! +%&'! ()! '%&C! +)'! 9%.4)&.'!

%. .)4&amp;.&apos;!+;&gt;?@!-;-!-+)&apos;!-+8&amp;&amp;5, !+8&&)3,'!'%4&'1!%=)*!+)'!,5'3(.%.'!8998'5'!983,! (, 3CC0,)! +8&*! :3)! (%! :3%&.474*%.48&! +)'! -8&8*I.)'! +%&'! ()! '%&C! 9, vol.4

. *!+)&apos;!%, :3)'!).!4&7, vol.9

!. +8&amp;&amp;5)&apos;!-+)&apos;!-)&amp;7%&amp;.&apos;!-&apos;%4&amp;&apos;!-&apos;8&amp;-;-!-*8&amp;, . Q(-;-a!-m8&apos;!-;-&amp;!-*8&amp;, !. Q(-;-a!-j%, and . %4, ! :3%&.! 6! )3H! '3CC0,)&.!:3)!*)!'8&.!()'!B$#[ f !*4,*3(%&, &.!+)!+4%C&8'.4:3)!()'!>?@!:3%&+!*)! '8&.! ()'! >O! :34! '8&.!, vol.9

. M83&apos;!-%=8&amp;&apos;!-5c%, , vol.3

%. *. 48&amp;!-+, ! -8&8*I.)'! '%&C34&'! )

, A!V)'!,5'3, vol.4

+. , ! 4&, 5+4%4,)'! ).! &8&! *(%''4:3)'! '%&C34&'! +)'! 9%.4)&.'! >O! *8-9%,5! %3H! )&7%&.'! %..)4&.'! +;>?@A! B)'! 8P'),=%.48&'! '8&.! 6! -)..,)! )&! ,)(%.48&! %=)*! W! 5.3+, p.34

&. , !*8-9%,%4'8&'!%=)*!+)'!+8&&)3,'!'%4&'A!M83'!%=8&'!+%&

!. +8&amp;&amp;5)&apos;!+)!os and &. &lt;i?&apos;s%!, !%(A!:34!8&.!8P'),=5!+)'!.%3H!+;)H9,)''48&!, vol.7

!. , ! '%&C34&'! +)! &83=)%3H! &5'! %, p.4

, 3+)1! (;)H9,)''48&! +)! B$YD! 5.%4.! 5C%()-)&.! 7%4P()! ).! (, pp.8-8

*. Ros and &. &lt;i&amp;&apos;s%!-).!-%(a1!-wffwta!-$%&amp;&apos;!-3&amp;!-&apos;)*8&amp;+!, ! >+)%.-0)%0#, )('0, p.5

*. I. , !4&.),-5+4%4

!. %&amp;, 4C5&4:3)!4-98, %&.)!983=%&.!7%=8,4'),!(, p.5

. 4&amp;7(%--%.48&amp;!-)&amp;!-*%&apos;!-+;&gt;?@a!-m8&apos;!-%&amp;%(i&apos;)&apos;!-+%&amp;&apos;!-(, NO! +)'! 9%.4)&.'! >?@! ).! >O! -8&.,)&.! 3&)!

!. , !4&.),-5+4%4

!. 9%, %. , and .. !. %3h!-&gt;o1!-%, ! :3)1! +)! 7%Z8&! 5.8&&%&.)1! )(()! ), vol.3, pp.4-98

*. and !. %4, 1! &83'! %=8&'! +5.)*.5! +)'! .%3H! +;)H9,)''48&!4-98, %3!&4=)%3!+)'!a!'83'K9893(%.48&'!+)!-8&8*I.)'!'%&C34&'!, vol.3

. +)&apos;!)&amp;7%&amp;.&apos;!%..)4&amp;.&apos;!+;3&amp;)!&gt;o!%4&amp;, !-8&8*I.)'!*(%, vol.3

*. ?l!-+)!-.i9)!-#!, %&.! 983,! (%! 9/%C8*I.8')! +)! *8-98'%&.'! P%*.5,4)&'! ).! '8&!, pp.4-98

, H9,)''48&! %! 5.5! +5-8&.,5)! *8--)! 983=%&.! ,%94+)

*. 8&amp;&amp;%4, %&*)!+3!-8.47!P%*.5,4)&!NJO!83!)&!9,5')&*)!+)!*),.%4&)'!*I.8S4&)'!Ro99)C%%,+!

!. %+3, ! :34! 8&.! *8-9%,5!(;)H9,)''48&!+)!B$D[!)&.,)!+, p.4

. &gt;o!-).!, 34! 8&.! 8P'),=5! 3&)! )H9,)''48&! 5, p.5

+. C%%, . !).!%(a1!wf#ata!g&amp;74&amp;1!&amp;8, !. )!%&amp;%(i&apos;)!+)!on&gt;m!%!-8&amp;.-;-!&gt;?@!9%, %. , and .. !. %3h!&gt;oa!, !%3!&4=)%3!+)'!a!'83'K9893(%.48&'!+)!-8&8*I.)'!+;)&7%&, vol.5, pp.4-98

&. )!-*8&amp;&amp;%4, %&*)1! 4(! &;)H4'.)! 9%'! +)! +8&&5)'! 93P(45)'!

). H9 and . +%&amp;&apos;!-3&amp;!-*8&amp;-;-!-+,

, 23=5&4()A! U83.)784'1! +)'! 5.3+)'! '3

&. +8&amp;&amp;)3, !:3)!(;)H9,)''48&!+)!ON>M!

. B$#d, !)'.!'4-4(%4,)!%3H!,5'3(.%.'!:3)!&83'!%=8&'!8P.)&3'!Rj87),!).!%(A1!WF#ETA!$%&'!, p.34

&. , ! (;%&%(I')! +)'! -%,:3)3,'! +

%. *. 4=%, 48&! )H9,4-5'! 6! (%! '3,7%*)! +)'! -8&8*I

&. !. &apos;!-&gt;?@!-), . &gt;o!--8&amp;, and . )&amp;.!-+)&apos;!-+4775, %&.)'! %3! &4=)%3! +3! '%&C! +)! *)'!, vol.9, pp.4-98

!. %=)*!, 4&.)&'4.5!+)!jN>K$L!).!+)!ON>M!:34!'8&.!-%28,4.%4

. +;&gt;?@!.%&amp;+4&apos;!-;-!b$d,

, ! '34'! 5C%()-)&.! 4&.5,)''5)! 6! (%! *%,%*.5,4'%.48&! 9/5&8.I94:3)! +)'! $B'! :34! '8&.! (

*. 49%3h!%*, 48&!%&.4C5&4:3)A!V)'!,5'3, vol.3, pp.3-4

!. and !. , , p.3

. %3*3&amp;)!-+4775, *)! &;)'.! '4C&474*%.4=)1! %(8, vol.4775

*. %. 4=, !'8&.!8P'),=5)'!+%&'!(, p.1

. 8p&apos;) and . =5)!-+%&amp;&apos;!-(, ! NO! +)'! 9%.4)&.'! %..)4&.'! +;>?@! *8-9%,5! %3H! )&7%&.'! %I%&.! 3&)! >OA! B)'! ,5'3, vol.4

*. 5+)&amp;, !5.3+)'!:34!8&.!-8&, p.3

$. B&apos;!)&apos;.!&apos;4c&amp;474*%, 4=)-)&.!'395,4)3,!+%&'!(, *3(%.48&'!>?@!*8-9%,5!%3!'%&C!95, vol.4

!. Wffyta!g&amp;!*%&apos;!+, !-b-)'!9%.4)&.'!RO-8()v'S%!).!%(A1

$. +%&amp;&apos;!-(-;-!-&apos;%&amp;c!-)&apos;.!-+4-4&amp;35!-9%, !. , %. , and .. !. , ! +)! *)'! ,5'3(.%.'! '3CC0,)! :3)! (;>?, %&.)!+)!*),.%4&'!'83'K.I9)'!+)!$B'!'3,!()!'4.)!4&7, vol.84

, %&&!).!%(A1!WFFkTA!c&)!+4-4&3.48&!+)!(;)H9,)''48&!+)!jN>K$L!9%,!(

!. and %. , 5)1!%''8*45)!6!3&)!9

. !-+)&apos;!-$b&apos;a!-g&amp;!, )77).1! '34.)! 6! 3&)! '.4-3(%.48&! 9%,! +3! NJO1! ()'! $B'! +)'! 9%.4)&.'! >O! 9,8+34')&.! -84&'! +)! *I.8S4&)'!, vol.9

, ! R.I9)! @NK#FT! :3)! ()'! $B'! +)! +8&&)3, vol.84

. +)&apos;!-$b&apos;!-%, %4.! (%! +57)&')! %&.4-4*,8P4)&&)

+. %**8 and . %=)*!-&amp;8&apos;!, &.! +%&'! ()! '%&C! 3&)! '83'K)H9,)''48&! +3! jN>K$L! %3!, vol.5, pp.34-42

!. ,

, !:3)!(;)H9,)''48&!+)!B$YD!'84, vol.9, p.5

&. &gt;o!9%, !. , %. , and .. !. %3h!&gt;, %&.)!6!(%!'3,7%*)!+)'!@&7$B'!+3!NO!+)'! )&7%&.'! %..)4&.'! +;>?@A! N;)H9,)''48&! 4-98, @1!)(()!)'.!9, pp.4-98

%. *. 48&amp;!-)&amp;!-*%&apos;!-+;&gt;?@!-%!,

. S%!-).!-%(a1!-wffyta!-b)&apos;!-$b&apos;!-%*.4=5, ! )H9,4-)&.! +)'! -8, pp.4-7

. !-u!, ! 9)3=)&.! %4&'4! 8,4)&.),! (%! 98(%,4'%.48&! (I

, !G&!)77).1!(, vol.3

!. B$#*-f-!*$b&apos;!7%=8,

, JL1! 4(! %! 5.5! -8&.,5! :3)! (

, H9,)''48&! +3! ,5*)9.)3,! ?!BK.I9)! ()*.4&!?! R?8&CP(8)+! ).! %(A1! WF#FTA! G&74&1! +)! 7%Z8&! 4&, vol.5

). H9 and . Nw!-)&apos;.!-&apos;i-;-&amp;!-*%&apos;!-+, , vol.78

, >O1! ).! *)! '3,! .83'! ()'! '83'K .I9)'! +)! $B'1! %3''4! P4)&! %3! &4=)%3! +3! '%&C! :3)! +3! NOA! G&! ')!, p.4

!. , ! (%! 78&*.48&! +)! *)'! *)

, !+8&&5)'!+)!t34C&%&.!)

. %. %3c-)&amp;, 48&! +)! (;)H9,)''48&! +)! J$NW! %9,0'! 3&

, %&.! +)! +5=)(899),! +)'! 4&7)*.48&'! &8'8*8-4%()'! Rt34C&%&.! ).! %(A1! WF##TA! $)'! 5.3+)'! ,5%(4'5)'!'3,!+)'!'83,4'!J$NW KzK !-8&.,)&.!:3)!()'!BJ>!9, vol.9, pp.4-98

%. and !. , ! (I-9/8*I.)'! U! *8-9%,5! %3H! *)

J. Nw!-)&apos;.!-+8&amp;*!-3&amp;!, 5C3(%.)3,! &5C%.47! +)! (;%*.4=%.48&! +)'! U1! &5*)''%4,)! 983,! (;4&+3*.48&! +)! .8(5,%&*)A!N%!9(3'!7%4P()!)H9,)''48&!+)!J$NW!%3!&4=)%3!+)!.83.)'!(

, ! 9%.4)&.'! >?@! )&! (8*%(! ).! )&! 95,49/5,4)! .5-84C&)! +8&*! +)! 9),.3,P%.48&'! %3! &4=)%3! +

*. %&amp;4, !)&+8C0&)'!, pp.4-9

, %4! 93! 8P'),=),! 3&)!

, %&.)! +)! -8&8*I.)'! %3! &4=)%3! +)'! %

Q. &gt;o1!*-;-!, !+%&'!(%!+57)&')!*8&

!. and !. , ! )&7%&.'! %..)4&.'! +;>?@1! (;)'')&.4)(! +)'! 9

8. !. +%&amp;&apos;!-(, , p.5

&. &apos;!&gt;?@!,

, )!+)'!(I

, !:3)1!P4)&!:3)!()'!-8&8*I.)'!'84)&.!9, %&.!+)!&8.), pp.4-98

!. 7%4p(-;-!-)&amp;!-*%&apos;!-+;&gt;?@!-9%, !. , %. , and .. !. %3h!-&gt;o1!-*,

!. +%&amp;&apos;!*)!-;-!*/-;-!um`k, !:3)!(, 8&4:3)A!G&!)77).1!+)'!5.3+)'!,5%(4'5)'!'3,!+)'!9%.4)&.'! >?@!-8&.,)&.!:3)!*)'!*), vol.283

4. &. Ro%h)&amp;%!-).!-%(a1!-wffex!-o and . %=%!, , pp.8-8

%. *. 48&amp;!, 4C5&4:3)! ).! %4&'4! (;)H%*), 4&.'! +;>?@A! c&! .)(! 9/5&8-0&)! 9)3.! b.,)! %**)&.35! 9%,! ()! 7%4.! :3)! ()! &8-P

*. I. )&apos;!u!%-;-!*%&apos;!+, , vol.4, pp.4-98

. &amp;8&apos;!-;-%.&apos;a!-!-!-#&quot;#!-!-b, &5#/1#5:0(/1#*(#6?/++1<16/):&5#()#*(#6?/+):0/):&5#*(4#4&14;3&316/):&54#*(# <&5&+=)(4#()#*(#-84#*1#6:[1:*(#4=5&0:/6#(5)%(#6(4#3/):(5)4#/))(:5)4#*?/%),%:), vol.5, p.1

, %:)(#'1095:6(#:*:&3/), vol.4

, /6=4(4#*(#6?(23%(44:&5#*, vol.4, p.4

. B8--)!-4&amp;+4-;-!*%+, ! 2)! -)! '34'! 5C%()-)&.! 4&.5,)''5)! %3! 9, H9,)''48&! +)'! -4>LM'!%3!&4=)%3!+3!'%&C!95,49/5,4:3)!).!+3!NO!+)'!)&7%&.'!%..)4&.'!+;>?@A!$%&'!(, p.874

. -%!, 40,)! 784'1! %=)*! (;)H9,)''48&! +)'! -4>LM'! +)'! 9%.4)&.'! >O! %74&! +;4+)&.474),! +)'! '4C&%.3,)'! 9, vol.89

*. 8&amp;&amp;3&apos;!983 and !. , , vol.3

, %&.!+)!+4'*,4-4&),!>?@!)

, !+, !()!+4%C&8'.4*!+)!*)'!+)3H!, vol.78

%. and %. , A! O4-4(%4,)-)&.!6!, vol.5

, 5!+)'!+4775,)&*)'!'4C&474*%.4=)'!)&.,)!>?@!)

. %3!-+3!-&apos;%&amp;c!-*, , vol.9

. !-%!, ! +4775,)&*)'! +;)H9,)''48&! )&.,)! *)'! !, 4+)&.474),! #k! -4>LM'! 9

. &amp;!-*%&apos;!-+;&gt;?@!-).!-e!-r-4lkd, DD"KE91! -4LK#EEKE91! -4LaakKa91! -4LKa[WKE9! %&+! -4LKD"#DKE9T! 9(3'! )H9,4-5'! )

%. .)4&amp;.&apos;!-+,

. &gt;oa!-&gt;74&amp;!-+)!-=%, ! *)..)! (4'.)! +)! -4>LM'1! 2

, %4! )77)*.35! +)'! LUK:JBL! '3,! 3&)!

!. No!+4775, &.!)H9,4-5'!)&.,)!>?@!).!

. B)&apos;!-+4775, ! +;3&)! 9%,.! 9%,! +)'! =%, vol.9

A. G&amp;!, , vol.8, p.77

%. %77 and !. */4, ! +4775,)&*)'! +3)'! %3H! 4&+4=4+3'A! $)

, +5P4.!)'.!3&)!.)*/&4:3)!9(3'!')&'4P()!:3)!(%!LUK:JBLA!J83,!*)..)!,%4'8&1!')3('!#F!-4>LM'!'3,! ()'!#k!,).)&3'!6!(%!'34.)!+3!'5:3)&Z%C)!8&.!93!b.,)!+5.)*.5'!+%&'!()!NO!%=)*!(

, ! ,)(%.47! 6! (;4+)&.474*%.48&! +)! P48-%,:3)3,'! +4%C&8, *8&'5:3)&.1! 983,! ,)-9, vol.4

&. Luk, JBL!).!9,5')&.%&.!+)'!+4775,)&*)'!'4C&474*%.4=)'!)&.,)!>?@!).!>OA!c&)!%&%(I')!

, !+)!LoB!%

, &4,!a!-4>LM'!%=)*!

!. %4, !+)!*8&74%&*)!+)!kE]!g!-4LKD"D[KE91!-4LK#EE!).! -4LK#[D%KE9A! V)'! ,5'3, &.! +8&*! :3)! (%! :3%&.474*%.48&! 9%,! LUK:JBL! +)! *)'! a! -4>LM'!%3!')4&!+3!NO!+)'!9%.4)&.'!>?@!).!>O!

, !()!+4%C&8'.4*!+)!*)'!-%(%+4)'A!M8.8&'!.83.)784'!:3;4(!)'.!4-98, pp.8-34

*. %&amp;%(i&apos;)&apos;!%=)*!+3!no!+;)&amp;7%&amp;.&apos;!%, 8=8:35)!9%,!3&!%3.,)!9%./8C0&)!:3)!

, ! :3)! ()'! -4>LM'! 4+)&.4745'! &)! '8&.! 9%'! %''8*45'! 6!

!. P%*, 4)A! G&74&1! 4(! '),%4.! 4&.5,)''%&.! +)! .)'.),! *)..)! '4C&%.3,)! +)! -4>LM'! '3, vol.5

. !-&gt;?@!-).!-+)&apos;!-&gt;o!-&amp;8&amp;!-*8&amp;74, ! 23=5&4(, ! 983,! =%(4+),! R83! &8&T! *)'! -%, vol.9, pp.4-9

!. 4&amp;.5,)&apos;&apos;%&amp;.!+)!*8&amp;&apos;4+5, !(;)&')-P()!+)'!#k!-4>LM'!4+)&.4745'!6!(%!'34, vol.3

!. , ! -%28,4.5! +)! *)'! -4>LM'! '8&.! +)'! -4>LM'! &83=)

-. %. 4&amp;78 and . 48&amp;&apos;!-+4&apos;98&amp;4p(, ! 6! ()3,! '32).! +%&'! (%! (4, A! B),.%4&'!'8&.!*)9)&+%&.!+5*,4.'!+%&'!+)'!-%(%+4)'!%3.8K4--3&)'A!B

, E9!:34!)'.!+5,5C3(5!+%&'!()!(393'!5,I./5-%.)3H!'I'.5-4:3)!).!(, pp.4-4

%. Wf#, X!j)<8=%!).!%(A1!WF#FT1!%4&'4!:3)!-4LKD"#DKE9!).!-4LKWkFk!+5*,4.'!+%&'!(%!JL!RN)&)

+. %&amp;+!`% and . V%, 4S! ).! %(A1! WF#ETA! J83,! *)! :34! )'.! +)! -4LK#[D%! ).! -4LK#EE1! 4

). %c4.!-+)!--4&gt;lm&apos;!+5*,4.&apos;!+%&amp;&apos;!+)!&amp;8-p and . 3h!%, !:3;4

*. 48&amp;!+)!*i.8s4&amp;, , vol.9, p.0

, 4&=),')1! -4LK#EE! )'.! *8&'4+5,5! *8--)! 3&! -4>LM! 9, vol.8, pp.34-38

&. 48&amp;!-+)&apos;!--8&amp;8*i.)&apos;!-)&amp;!--%*, 89/%C)'! )&! *4P(%&.! +)'! C0&)'! .)('! :3)! !Q@!C! R?O399,)''8,! 87! *I.8S4&)! '4C&%(4&C! #!?T1! @!<CP! RV%*,89/%C)! *8

T. Ro, , vol.8

). H9 and . &apos;&apos;48&amp;!-+)!-*)&apos;!-+)3h!--4&gt;lm&apos;!-+%&amp;&apos;!-(-;-%&apos;-%!-8&amp;.!--8&amp;, ! +)'! &4=)%3H! +;)H9,)''48&! %P),%&, ! ()'! 9%.4)&.'! >?@! *8-9%,5! 6! +)'! )&7%&.'! '%4&'! RV%! ).! %(A1! WF#DTA! J%, vol.5

, ! 4&7)*.4)3HA! B;)'.! ()! *%'! +)! -4LKa, %4! 4+)&.47451! *),.%4&'! '8&.! 5C%()-)&.! +5*,4.'! +%&'! +)'! *8&

, !Rp%&C!).!%(A1!WF#WT1!83!)&*8,)!()!-4LK, vol.4, p.3

, H9,)''48&! %3C-)&.)! )&! ,598&')! 6! 3&)! 4&7)*.48&! 6! 5*-3%

*. , 8&%4,)'! RN4! ).! %(A1! WF#ETA! J83,! *)! :34! )'.! +)! -4LK#EFKE91! 4(! )'.! '3,)H9,4-5!+%&'!+)'!JdVB!+^)&7%&.'!>?@!9%,!,%998, vol.93

, 4&=),')1! 7%4P()-)&.! )H9,4-5! +%&'! ()! '5,3-! +)! 9%.4)&.'! %, p.4

!. 9% and .. !. %998, *3!).!%(A1!WFFkT1!*)!:34!)'.!)&!%**8

!. 7%z8&amp;!-4&amp;, )! C0&)'! %99%,.)&%&.! 6! +)'! =84)'! +)! '4C&%(4'%.48&!(45)'!6!(;4&'3(4&)A!d4)&!:3)!*)'!=84)'!&)!'84)&.!9%'!)&*8, vol.5, pp.4-9

+. , !:3)!(%!9,5=%()&*)!+)!(%!,5'4'.%&*)!6!, vol.5

. %. 3+)&apos;!8&amp;.!*8&amp;&apos;, !:3)!()'!)&7%&, 4&.'!+)!-%(%+4)'!4&7, vol.84

!. I9)!-w!, 45! 6! 3&)! ,5'4'.%&*)! 6! (;4&'3(4&)! 9,5')&.%4)&.! 3&! ,).%,+! +)! *,84, pp.4-98

. !-!-#, ! ).! %(A1! WF#YTA! B)! +),&4)

*. 8&amp;*)&amp; and %. ;-a!-g&amp;!, ! +)! *I.8S4&)'!, vol.9, p.77

!. , ! :3)! ()'! *8&*)&.,%.48&'! 5()=5)'! +, vol.5

. @nkd!-*/)&lt;!-+,

, 8*45)'!6!+)!7%4P()'!.%3H!'5,4:3)'!+;@t`K#!).!6!3&!,).%,+!+)!*,84

, C0&)'! (45'! 6! (%! ,5'4'.%&*)! 6! (;4&'3(4&)A! B)*4! 9

, !)&7%&.'!%..)4&.'! +;>?@A! N;)&')-P()! +)! *)'! %&%(I')'! %=)*! (, ! -4>LM'! %998

. !-+;%3, &+,)! +)'! =84)'! +)! '4C&%(4'%.48&'!, vol.4, p.35

, ! %3! &4=)%3! +3! '%&C! ).! *)(34! +%&'! (, vol.3

, 8&4:3)A!V)'!,5'3, 40,)! 784'! 3&)! %**3-3(%.48&! +)! -8&8*I.)'! 4&.),-5+4%4,)'! %3! &4=)%3! +3! NO! +)'! )&7%&

%. .)4&amp;.&apos;!+-;-!*%&apos;!+;&gt;?@!, 1!*)!:34!)'.!)&!%**8,+!%=)*!+)'!+8&&5)'!93P(45)'!'3, vol.8

, Rt%3,!).!%(A1!WF#"TA!B8--)!)H9(4:35!*4K+

. B$#d-f-!-%!-5, 5! 4+)&.4745)! +%&'! +)! &8-P,)3')'! 9%./8(8C4

%. ,

8. &amp;=4, , vol.4

!. , A. , and +. U3%4, 8&!R@MOGLV!c#FEYT!983,!%&%(I'),!(, vol.5, p.349

!. +3!, , vol.5, p.5

!. No!-9%, !. , %. , .. !. %3!-&apos;%&amp;c1!-983=%&amp;.!-&apos;3cc5, ). et al., ! +)! -8&8*I.)'! %3!

. !-+)&apos;!-%, 48&'! +)'! 9%.4)&.'A! $)'! *I.8S4&)'!, vol.4

. @nk#y1!(;@nkd!).!-;-!noa!b, 8&.!5C%()-)&.!5.5!+5.)*.5)'!)&!*8&*)&.,%.48&'!5()=5)'!+%&'!(

, ! +8&&5)'! +)! O%H)&%! )

&. , ! -8&8*I, ! +)! 9%.4)&.'! %..)4&.'! +;>?@! ).! *8&.,4P3),! %3! +5=

, @NK#?!).!@NK#Y!, vol.5, issue.8

, !-8&8*I.)'z-%*,89/%C)'!+)!(;%,.4*3(%.48&A!G&74&1!(%! 9,5')&*)! +)! @`M%! )'.! 3&)! *I.8S4&)! '4C&%.3,)! +)'! B$#Wa f ! 9$B'! :3)! 2;%4! ,).,83=5)'! )&! :3%&

. %4!-*/, ! (;)77).! +3! NO! +)! 9%.4)&.'! %..)4&.'! +;>?@! '3,! +)'! -8&8*I, */5! 6! *%,%*.5,4')

, ! +)! +8&&)3,'! '%4&'A! N)'! %&%(I')'! 9/5&8.I94:3)'! +)'! -8&8*I

, P, vol.3, issue.3

*. , !:34!%*:340,)&.!3&!9/5&8.I9)!'4-4(%4,)!6!*)(34!+)'!-8&8*I.)'!4&

). &amp;+,

, %4&'1! 2)! -)! '34'! 4&.5,)''5)! %3H! -4>LM'! :3)! 2;%=%4'! 4+)&.4745'! +%&'! ()! NO! +)'! >?@1! ), vol.9

!. , !:3)!-4LK#EFKE9!)

*. , !(I-9/8h+)'!Rj)!).!%(A1!WF#[TA!$)!9(3'1!+)'!5.3+)'!,5*)&.)'!8&, =4)&.!+%&'!(%!+4775,)&*4%.48&!.),-4&%()!+)'!-8&8*I.)'!=4%!()!*4P

%. #ef!-+4-4&amp;3)!-(%!-c5&amp;5 and . 48&amp;!-+)!--8&amp;8*i, ! 4&, 5+4%4,)'1! *)! :34! )'.! )&! %**8,+! %=)*! -)'! ,5'3

. %4!*/, */5!+)'!C0&)'!98.)&.4)(()-)&.!*4P(5'!9%,!-4LK#EFKE9!:34!983,%4)&.!b.,)! -8+3(5'!%3!&4=)%3!+)'!-8&8*I.)'!).!:34!283),%4)&.!3&!,Q()!+%&'!(%!9/I'489%./8(8C4)!+)!(;>?@A! t,%*)!6!3&)!%&%

, %4!4+)&.4745!3&)!(4'.)!+)!C0&)'!).!-8&!4&, vol.5

. 7%z8&amp;!4&amp;, %&.)1!'8&!)H9,)''48&!)'.!78,.)!6!(%!'3,7%*)!+)'!-8&8*I.)'!*(%, vol.5

!. , ! &8&! *(%''4:3)'A! @(! )'.! 4-9, vol.3

!. ,

, ! )&! ,598&')! %3H! *8&*)&.,%.48&'! +)! VBJK#1! */4-48S4&)!, vol.84

!. and %. , %&.)'!+%&'!()!NO!+)'!9%.4)&.'!%..)4&.'!+;>?@!Rp)P),!).!%(A1!, pp.4-98

, WFFFTA! B)! ,5*)9.)3,! %! 5C%

, %&.4C5&4:3)! Rq/%&C! ).! %(A1! WFFkTA! V)'! ,5'3(.%.'! 4&+4:3)&.! 983,! (%! 9

). !+)!(;)h9 and !. , :3)&.1!()'!.%3H!4-98, vol.5

. %3!-&apos;)4&amp;!-+)&apos;!-%, 48&'! +)'! )&7%&.'! %I%&.! 3&)! >?@! 983,%4)&.! 4&+34,)! 3&)! +4-4&3.48&! +)!, vol.4

). H9 and . &apos;&apos;48&amp;!-+)!-@@pg1!-&apos;34=4)!-+;3&amp;)!, 48&! +)! (%! -4C,%.48&! +)'! -8&8*I.)'A! B)*4! 983

, !, issue.8

%. .)4&amp;.&apos;!+, >?@1!)&.,).)&%&.!%4&'4!(%!,5%*.48&!4&7, vol.84

. G&amp;!-*8&amp;*, 48&1! 2

. %. %4!-*8&amp;&apos;, ! :3;4(! )H4'.)! 3&)! %**3-3(%.48&! +)! -8&8*I, ! 4&.),-5+4%4,)'! %3!

!. No!-+, ! 9%.4)&.'! %..)4&.'! +;>?@A! N)'! 5.3+)'! :3)! 2

!. , ). , and Q. , !:3;4(!983, %4! )77)*.35)'! '3, vol.283

!. V8&amp;!-9, , vol.82

). &. %!-9-;-!--)..,)!-)&amp;!-5=4+)&amp;*)!-+4775 and . &apos;!-%*, ! *)((3(%4,)'! ).! -8(5*3(%4,)'! 983=%&, ! '83'K9893(%.48&'!+)!*), vol.3, pp.4-9

. !-+)!-$b&apos;!-)&amp;!-&amp;8-p, , pp.4-98

. B$#wa-f-!-9$b&apos;ta!-b, ! $B'! )H9,4-)&.! +)'! .%3H! 7%4P(, ! +)! J$NW! *8-9%,5! %3H! 9%.4)&.'! %..)4&.'! +

%. &gt;o1!-&apos;3cc5 and . !-;-!-+)!--8&amp;8*i, ! (I-9/8*I.)'! UA! $)! 9(3'1! (;%&%(I')! +)'!, (%4,)'! )&.,)! ()! '%&C! ).! ()! NO! +)'! 9%.4)&.'! %..)4&.'! +;>?@! -8&.,)! 3&)! %**3-3(%.48&! 4-98, vol.4

, 83.)784'!:3)1!983,!=%(4+),!*)'!,5'3(.%.'1!4(!)'.! 4-98, %&.!+;)77)*.3),!+)!&83=)(()'!4&*(3'48&'!+)!9%.4)&.'!>?@!).!>O!%I%&.!+)'! ?C)'!

. %74&amp;!+)!&apos;,

%. %77, !. */4, 4. =%, and . 48&amp;&apos;!*, , p.3

*. and %. , ! +;)H9,)''48&! +)'! -4>LM'1! 2, vol.5

, %4! 4+)&.4745! 3&)! (4'.)! +)! -%,:3)3,'! +3! NO! +4775, vol.84

!. 9%, *3(40,)-)&.!4&.5,)''5)!6!-4LK#EFKE9!).!-)'!,5'3, vol.4, p.3

!. , &.! )H9,4-5! )&! *%'! +;>?@! '),%4.! 4-9, vol.78

-. ). 4&amp; and ). %3!&apos;)4&amp;!+)&apos;!%, *3(%.48&'!+)'!9%.4)&.'A!G&!), vol.4, p.77

%. and %. 48&amp;!+)!-8&amp;8*i, !4&.),-5+4%4,)'!6!9%,.4,!+)!-8&8*I.)'!*(%, vol.4

!. , 5! +%&'! (%! (4..5,%.3,)! RO)(4-8C(3Kd3).! ).! %(A1! WF#YT1! -)'! ,5'3

!. and ). @@pga!-b, %4.! %=84,! 983,! *8&'5:3)&*)! +)! ,5+34,)!(%!-8P4(4.5!+)'!-8&8*I.)'!).!%4&'4!, vol.3, pp.4-983

!. =%, 4+),!(%!(4%4'8&!+3!+4,)*.)!+3!-4LK#EFKE9!%3!&4=)%3!+)!(%!'5

!. C0&amp;)!-@@pg1!-4-;-!%&apos;&apos;%ita!j83 and !. , ! &5*)''%4,)! +;)77)*.3),! +)'! %&%(I')'! %=)*! 3&! 'I

, 3&!%H)!+)!,5C3(%.48&!-4LK#EFzBBLW!+%&'!(

*. I. , 1! 4(! '),%! &5*)''%4,)! +

!. Bblw!-+%&amp;&apos;!-+)&apos;!-b$#, 8*45)'! 6! (%! '3,)H9,)''48&z4&/4P4.48&! +)

, ! +)! (;)H9,)''48&! C5&4:3)! ).! 9, vol.8, p.3

.. 4. 9%, !. No!-+)!-9%-;-!-%..)4&amp;.&apos;!-+;&gt;?@!-+)=, and . 8&amp;, ! )77)*.35)'A! $)! 9(3'1! ()'! 5.3+)'! :3)! 2, ! +)! 9%.4)&.'! %4&'4! :3)! *)3H! .,%&'7

*. and %. *. , 48&! 9/5&8.I94:3)A! @(! '),%4.! 4&.5,)''%&.! +)! (, vol.983

). !*;)&apos;.k6k+4 and %. , !*I.8S4&)'!9, 8+34.)'!9%,!*)'!*)

%. *. 48&amp;!-+)!-*, &40,)'1! (, p.3

!. %&amp;, 4C5&4:3)! ).!

, ! '83,4'! -4LK#EF KzK ! )H4'.%&.1! 4(! '),%4.! 4&.5,)''%&.! +;4&+34,)! 3&)! %, vol.9

. !)&apos;.!=, %4)1!(;%P')&*)!+)!-4LK#EF!+)=,%4.!9,8.5C),!(, pp.4-7

, ! 01, 0?(! '),8&.! 6! %99,878&+4,! )&'34.)! %=)*! +)'! 5.3+)'! 78&*.48&&)((

*. I. ,

, 3'!'83,4'!-4LK#EF fzf A! G&74&1!P4)&!:3)!2)!-)!'84'!4&.5,)''5)!+%&'!3&!9

!. &gt;a!rwffyta!@&amp;, &+,)! ()'! -5*%&4'-)'!, vol.3, pp.4-9

. *!%, 4.4'!'I&8=4%(!7(34+!%&+!4&+3*)!'I&8=4%(!74P,8P(%'.'!.8!9, vol.9

*. , 4H!-).%((89,8.)4&%')'A!?

V. &gt;cc%, . O%, and . %&amp;c41!&gt;ama1!t%3,

&. %. and !. Va?a1!j),

. I1!laga1!u3*s,

. Rwffwta!u/)!)%,(i!9%, &!87!284&.!4&=8(=)-)&.!9, vol.8, p.48

, >(8&'8KL34<1!>A1!J428%&1!?A@A1!>&'3%.)C341!GA1!c,S%,)C41!>A1!B%(%P8<81!VA1!%&+!x34&.%&%1!>A!

*. 4c)&amp;!rjn&gt;t and !. Lz$xz$j!%,

!. Rwffata and %. *. %(s4&amp;)!j,

. +a!clh1!#&quot;f#w#&quot;f&quot;a!-d%&amp;*/, %31!?A1!d,4),)1!`A1!B%3H1!BA1!$%=83'.1!?A1!N)P)*:3)1!OA1!N431!sAK?A1!J3()&+,%&1!dA1!%&+!

!. %&amp;+!`%.-;-!ga!r#kk and ;. , 3S4&!D!*%3')'!C,8v./!4-9%4, vol.8, p.4

%. and ). 4&amp;, , vol.3

, 8&1!NA1!`%'./1!>A1!>&+),''8&Kt?,)1!dA1!i,4'.4&''8&1!?A1!N%/+)&&

!. O=)&amp;&apos;&apos;8&amp;1!ga1!%&amp;+!m8 and . +4*!o.3+i!t-;-!maoa!rwff#ta!b8&amp;,

. *!*83&amp;, &%.48&%(!N), vol.4, p.3

, 8&KL4&)/%,.1!OA1!B, vol.8, p.1

, !MAUA1!i4-3,%1!sA1!N%H),1!LAVA1!N8=)

, L/)3-%.8(8CI!,)*8--)&+%.48&'!78, vol.87, p.4

*. , , vol.78

. A!&gt;, A!Rj8P8S)&TA!FK1!

!. C)&amp;1!jaba and . Rwf#fta!&gt;+%9, , pp.4-7

, */),1!JA>A1!j4CC4&'1!tABA1!>+%-'1!dA1!VI),'1!NAiA1!p%, p.1

. =%&amp;!+)&amp;!d, 8)S1!UA1!j899)&,)42'1!GA1!V), +4&C1!?A1!O*/8(-%&1!LA1!o..)&1!jAtA1!Ov%

.. V%, !. %ss)&amp;1!da1, !. %&amp;+!+)!?%c),1!pa, !. Rwf#eta!bi-;-%, and . %&amp;, 4&C!%.!+4')%')!8&').g!'3998,.! 78,!*(%''474*%.48&!87!I83&C!%&.4&3*(, vol.8, p.9
URL : https://hal.archives-ouvertes.fr/hal-00414518

. *!%,

P. B%9% and %. , , pp.3-7

, !4+489%./4*!%,./,4.4'!R9?@>T!4&/4P4.'!+477),)&.4%.48&1! -4&),%(4<%.48&!%&+!-%I!4&*,)%')!%989

!. B/)&amp;1!?akxa1, , p.1

. Rwf#&quot;ta!v4* and ). 8lm&gt;!)h9, !4+)&.47I!+4')%')K'9)*474*!%(.),%.48&'!4&!'I'.)-4*!(393'! ),I./)-%.8'3'!%&+!, vol.9

, 1!tAdA1!d%, pp.4-81

M. O@o!op-;-%, *. 8c, and %. -a!?a!b, >&%(I'4'!, vol.7, pp.4-8

, B/431!dAKBA1!`,))-%&1!BAVA1!O.8(P),C1!\ALA1!j31!?AOA1!q)4P)*8C(831!iA1!N31!dA1!t

. 4&amp;!,

!. ,

*. I. )a!g3 and A. !b)((a!v%-;-!ja!rwf#dta!&gt;-;-a!m%.a!l)=a!l, !+)&+,4.4*!*)((!73&*.48&'!4&!%3.84--3&)!+4')%')'g! +4'.4&*.!%&+!8=),(%994&C!9, vol.874

B. ,

%. J%, B,8'1!?A1!B%C&%,+1!MA1!p88

%. Unly!, , vol.8, p.9

, 1!@AiA1!d,%*S)1!iALA1!V%)'1!UA1!?88'1!tA`A1!%&+!d, vol.3

, wakaA! ),)((1!GAtA1!J8&+),1!NA>A1!V4&8,1!NAOA1!>&C)()'Kj%&1!OAUA1!i)&&)+I1!BApA1!L83

!. , !L/)3-%.8(A!IC1!E["wEEaA! (%.-1!dA1!j877-%&&K\8(+1!>AKVA1!L)4771!>A1!`-,)1!-IA1!N4)&1!tA1!%&+!\4&2)1!oA!RWFFDTA!N8&CK

. +!%, *8-)!%&+!9,8C&8'.4*!7%*.8,'!4&!)&./)'4.4'K

. !$a1!p4, S8v'S41!jA1!j%--),'*/-4+.1!@A1!p3(77,%%.1!MA1!O*/-)(4&C1!jA1!`,8'*/1!VA1! j8,&)771!tA1!i34'1!pA1!O8,C1!BA1!%&+!L8./1!?A!RWFF, vol.89

. !$a1!p4, S8v'S41!jA1!\8C(1!UA1!%&+!L8./1!?A!RWFF"%TA!O#FF!9,8.)4&'!)H9

. !$a1!p4, S8v'S41!jA1!%&+!L8./1!?A!RWFF"PTA!V)*/%&4'-'!87!$4')%')g!%!'$>VJ'!=4)v!87!

, %1!@A$A1!%&+! 8&')*%1!`A>AjA!RWF#"TA!V8&8*I.)!'3P.I9

*. +48=%&apos;*3(% and !. +4&apos;)%&apos;)a!b(4&amp;a!o*4a!rn8&amp;+ta!ckc1!#w#ew#ww, , pp.4-5

-. I8a!?a!gh9a!v)+a!gcb1!wyaawwy,

, 4C48&)1!@A1!V8,%&+41!`A1!t,)C8,481!>A1!B/4)'%1!OA1!`)

.. &gt;a1!t%-p4&amp;41!ba1!v% and . 4&amp;41!&gt;a1!, , p.4

, C8,481!>A1!`),(4.81!`A1!L8''41!`A1!?%,8''%I1!$A1!N%&<%=)**/4%1!>A1!

.. V%, !. 4&amp;41!&gt;a1!%&amp;+!v%&amp;&lt;1!vata, and . Rwffdta!$, 4&*.!)H9,)''48&!9%..),&!87!@`MK!!%&+!UM`K!!4&!23=)&4(
URL : https://hal.archives-ouvertes.fr/hal-00414518

, C8,481!>A1!`)

.. V%, !. Vata, and . Rwff, TA!$4'.4&*.!)H9,)''48&!9%..),&!87!@`MK%

!. Vi(-;-!&gt;a1!v4&apos;, ;. %1!la1!%&amp;+!&gt;cc%, and . @&amp;, , p.4

*. and ). %&apos;)+!4&amp;, , p.4

!. Ta!c9+%, 8&!./)!9%./8C)&)'4'!%&+!

. *!%,

!. , , vol.8

, 4&*,)%')+!-8,.%(4.I1!&8'8*8-4%(!4&7)*.48&!%&+!4--3&)!+I'73&*.48&'!4&!, p.9

B. B% and ). Lkka!-t34, 4%-'1!VA1!t4&/83H1!`A1!?%S3P<4*S1!BA1!M%4S1!OAjA1!o&%41!MA1!O*/,%-(1!dAcA1!O)C3,%1!GA1! U3''4v%&+1!LA1!%&+!s8&%1!OA!RWF#, p.89

!. , P. &apos;si1!?apa, and !. Rwf#ata!c9+%, AtA1!i)''(

. *!&gt;, , p.9

, <8=%1!LA1!O(%PI1!oA1!`%(.)2'S8=%1!JA1!V4S3(S8=%1!qA1!d3,)'8=%1!@A1!L%2%1!iALAVA1!j8+)S1!?A1! o=)'&%1!?A1!%&+!V4*/%()S1!?A!RWF#FTA!-4*, p.1

*. We#wwe, A! j4&S'1!>A1!d%, 8&1!>A1!O/)9/%,+1!MA1!GI,)1!OA1!d8v)'1!?A1!B%, p.4

. O*/3p, /1!VA1!N)=4&1!?A1!$%&)S1!>A1!L8..),1!dA1!).!%(A!RWF#ETA!'(%&K+), p.74

!. , %1!iA1!?4&%1!MA1!G++%83+41!>A1!U/8-'8&1!pA1!j3P%&S1!VA1!%&+!p)++),P3,&1! NALA!RWF#FTA!d48(8C4*!9, pp.4-489

, -4&)+!7,8-!'I&8=4%(!7(34+!*)((3(%,!*8-98'4.48&!%&+!C)&)!)H9,)''48&A!>

J. and %. &amp;1!da?a!rwff, TA!d(88+!%&+!'I&8=4%(!7(34+!*I.8S4&)!'4C&%.3,)'!4&!9%

@. #k, wW#DA! ?8&CP(8)+1!OANA1!i%''4%&8'1!>A?A1!V*$8&%(+1!iA?A1!B(%,S1!tA?A1!?31!uA1!>&C)(1!BAGA1!B/)&1!BAK?A?A1!

$. 3&amp;p%, !. Jala1!p%+, and ;. I1!lada1,

. R$b&apos;t!,

. +a!gbh1!#w,

!. %&amp;+!j3pp%, !. +1!?ada, !. Rwf#kta, and . &gt;&amp;%,

!. Oa1!j, %7&S)('+"..4,1!iA1!i()4&1!VALA1!+)!?%C),1!pA1!j%=),S%-91!VAjA1!=%&!d4(')&1!?AjA1!

!. Vaja1, !. %&amp;+!j, and . %ss)&amp;1!da?a!rwffdta!m8=, )4&%')Ka!+,4=)!+4'.4&*.!%3.8,)%*.4=)!UK*)((! ,)'98&')'!4&!23=), p.4

!. Vi,

!. &gt;ala1!o, &1!?ANA1!G&C(%&+1!OA?A1!j3%&C1!sAKOA1!`)C%&1!iAjA1!$), pp.4-81

!. Ja$-;-!g and I. /. , A1!p%3C/1!LAGA1!%&+!J%(4'1!?A!RWF#ETA!d-4K#!L)C3(%.)'!GH.)&'4=), p.7

). &amp;&amp;1!\a1!v8 and . &lt;1!na1!j-;-!la1!j%, 4&81!tA1!i4)&%97)(1!jA1!>'*/)

A. , %. *. A!gcb1!-;-!%&amp;+!j), and &. Rwff, kw"YDA! i3,%/%,%1!$AiA1!t,%&+4&)..41!>A1!`32441!NANA>A1!U8S3+%1!>A>A1!t%(%,481!?A>A1!j%&1!VA?A1!U),)((1!VA?A1! s%-%-8.81!iAOA1!s%-%C%1!iAVA1

. =%,

I. , /)-%.8'3'!%*,8''!+4'9),')+!C)8C,%9/4*!%

!. Ta!b/%, %. *. , 4. 48&amp;!%&amp;+!, and ). , 4&41!tA1, %74&41!dA1!L8'4*%,)((41!dA1!O)P%'.4%&41!tA$A1!V4&4'8(%1!tA1!U%,%&.4&81! cA1!L4**4),41!\A1!\%(, vol.34

, H9,)''48&!87!-4LM>K#EE!, vol.9

&. &apos;a!n393&apos;!gi1!w[fww, A! N%.*/-%&1!sA1!p88+1!BALA1!B/),&8=%1!UA1!B/%3+/%,I1!$A1!d8,+)1!VA1!B/), pp.8-9

. N8&amp;c1!&gt;a?a1!d,8v&amp;1!?a&gt;a1!m3&amp;-;-!la1!).!%(a!rwff#ta!j$knw!-;-!j$k#!%&amp;+!4&amp;/4p4,

!. Laba1!-;-!lana1!%&amp;+!&gt;-p-;-!\a!r#kkata and !. Ba!, , pp.4-7

!. +81!$apa and !. Rwf#, TA!$).)*, issue.1

!. Ba&gt;a1!%&amp;+!b/%,81, !. @a`a!rwffata, !. , and ). %&apos;)+!%, &4S1!JA1!j%'S), vol.8

. =)%(&apos;!%!, 8C)&)'4'A!?, vol.8

*. S1!?ala!r#ky#ta and !. , , p.4

J. , , vol.8

!. W#!8&amp;!-;-%, !?>izOU>U!'4C&%(4&C!9%./v%I!4&!./)!9, vol.49

. !%(a!rwf#eta!d3, S/8(+),4%!9')3+8-%(()4!'3,=4=%(!4&!(3&C!)94./)(4%(!*)(('!P)&)74.'!, vol.7, pp.8-12

. +!&apos;, 48&!87!>Ut#FA!>3.89/%CI!CC1!#Wkaw#aF"A! N8, vol.399

!. B%-9%1!&gt;a1!o4-;-!oada and !. #y!, =%1!BA>A>A1!i4''1!VAjAdA1!%&+!V)

%. and S. , !87!+4')%')!%*.4=4.I!%&+!')=),4.I!4&!9%.4)&.'!v4, vol.23, p.4

*. , 8. , and ). 23=, , p.4

!. J% and . S1!?ana1!%&amp;+!v, , p.94

!. S1!?ana1!o%&amp;+p8 and . C1!-ba1!%&amp;+!v,

!. Rwffwta!, V%*$8&%(+1!iAJA>A1!V3&'.),1!$A?A1!B(%,S1!tA?A1!$<48&)S1!>A1!O*/-4.<1!?A1!%&+!j%

%. B/%, 4<%.48&!87!/3-%&!P(88+!+)&+
URL : https://hal.archives-ouvertes.fr/jpa-00214957

. V%*n)&amp;&amp;%&amp;1!@a1!%&amp;+!\4&amp;3)&apos;%1!ba!rwffwta!$, &+,4.4*!*)(('1!d>``1!%&+!>JL@Ng!4&&%.)!9(%I),'!4&! %+%9.4=)!%&.4P8+I!,)'98&')

-. V%(4s1!$a1!o/% and . %&amp;+!i%3,

!. %&amp;1!pa1!%&amp;+!o*/%3)&amp;&apos;.)4&amp;1!ia!r#kketa, 3-!*I.8S4&)'!4&!23=)&4()!,/)3-%.84+!%, vol.8

, V%&&),'1!JA1!N)''(4)1!?A1!O9)(+)v4&+)1!$A1!%&+!U3&P,4+C)1!$A!RWFFaTA!B(%''474

. *!%, , vol.83

.. 4. V% and !. &gt;a!rwffata, &3-P),!87!284&.'!4&=8(=)+!8, vol.9

. V%, 4&41!>A1!L%=)((41!>A1!>=*4&1!UA1!d),)'78,+1!VApA1!d3,C8'K\%,C%'1!LA1!B3

*. N%h, 4%! 78,!?3=)&4()!@+489%, vol.4

!. %&amp;+!`%(*4&amp;41!`a!rwff[ta!o, 4&!RoJtTzL>MiKN!'I'.)-!4&!23=), vol.89, p.4

, !oJtzL>MiKN!4&!P8&)!4&23, vol.8

!. B% and %. *)+81!?a!rwf##ta!, 4&81!>A1!d3)&+4%1!JA1!V%,.4&KV%(81!>A1!>(2%-%1!JA1!L%-4

!. *)&amp;.!b$#[fb$#df, !)H/4P4, vol.9

*. S1!ja?a!rwf##ta!&gt;*.4=%,

!. 284&amp;, !v4./!23=)&4()!4+489%

,. V3 and . %i1!ia, A1!N3I,4&S1!NA1!t,8-1!>A>A1!J%''81!VAjA1!G-), p.1

*. 8&amp;4*!%,

, 4&C!'3CC)'.'!+I, vol.9, p.3

). M%/, !. &amp;+8, and . Va1!ov4, S41!`AiA1!>4S%v%1!GA1!O.%&C)&P),C1!NA1!p3,+4&C),1!UA1!`4C3)4,)+81!?AKNA1!

!. Va?a!rwff&quot;ta!u/,

. Rwffyta!gh9,

, 4'.%&*)1!%&+!+4%P).)'A!, M4*8(%31!?A1!N):3),51!UA1!d%*:3).1!jA1!%&+!\4, vol.8

!. Vava?a1!=%&amp;!o*/%% and +. C1!$a1!l,

, 3+I!87!'), vol.4, p.4

. Rwffyta!@&amp;, 3S4&K#"w9,8+3*4&C!U!*)(('!%,)!)&,4*/)+!4&!./)!284&, vol.87

!. %=)!%!, , vol.49

!. Oa1!`%**48, 41!`A1!t,3%,4&1!JA1

!. V8, 81!VA1!B,8'.41!VA1!).!%(A!RWF#aTA!j3-%&!B$#*f!+)&+,4.4*!*)

*. Wa!-o, 98&')'A!d(88+!CGG1!kaWwk

!. Ta!v4*, B8&&)((1!LAVA1!U%C%&8=1!iA$A1!d8(+4&1!VAJA1!B/)&C1!tA1!%&+!d%, p.8

C. V%-;, 8&1!JAMA1!B%P,%(1!$A>A1!L8')&P)

. I1!laga1!l,

!. Va!rwffata and !. G%, +4*.8,'!87!(8&C.), p.83

!. ,

, o841!iAtAK?A1!t%(%.8v4*<1!tA1!U8v(

!. %&amp;+!@`m?!j, BI.8S4&)!$).)*.48&!=),'3'!GN@O>!78,!>:3)83'!j3-8,g!@NKE1!@NK#F1, vol.874

!. Ba$a1!b%?,

!. Gajaoa1, . I1!ja1!`)%, and . 8&amp;1!ca1!).!%(a!rwf#&quot;ta!oi&amp;8=4%, , p.4

!. Ba1!&gt;(=% and . %+8!$)!n%!d%, %1!BA1!N"9)<K\4+%(1!sA1!\"<:3)<KV)((%+81!?A1!L4*/%3+K

, J%.4&1!sA1!>-4)=%1!LA@A1!N(8,)&.)1!NA1!V%,.?&)<1!>A1!q??4C%1!?A1!B473)&.)'K>, p.81

*. %&amp;+!$,

$. Aba1!d%-;-!gaga1!$)c&amp;%&amp;1!da1, !. V?-;-!ja1!).!%(a!rwfffta!b8&amp;-;-!ibd1!ydwyka, and !. J%, =%.48&!87!./)!'):3)&*)!%&+! .)-98,%(!)H9,)''48&!87!(, vol.3, p.4

, C3(%.)+!-4LK#[D%!)H9,)''48&!4&!9

A. L#f#a!,

!. Ma, A1!i/%v%2%1!iA1!VI),'1!>A1!?8&)'1!$A1!B%v'.8&1!UAGA1!L8v%&1!>A$A1!%&+, p.1

, 4&%')!RVVJTK#!4&!9%4,)+!'),%!%&+!'I&8=4%

. *!%,

, I1!LAGA1!O83./v88+1!UALA1!d%3-1!?A1!d

!. V%, %I1!GA1!t(%''1!$AMA1!V%&&), pp.8-8

!. &gt;ava!r#kkyta and !. , , vol.3, p.4

. +!*,

, I1!LAGA1!O-4./1!?ALA1!%&+!L8')&P%3-1!?AUA!RWFFaTA!>, p.3

, I1!LAGA1!O83./v88+1!UALA1!V%&&),'1!JA1!d%3-1!?A1!t(%''1!$AMA1!t8(+)&P)

!. 4+489%,

, !NA1!s%++%&%93+41!OABAOA1!@I)&C%,1!LA1!i4-1!$AK?A1!j)%,&1!OA>A1!$%&78

. V%--%,i!g94, /)(4%(!B)(('A!JN8O!o&)!J1!)#aE#EA!

, %&&1!jA1!O*/)78(+1!?ABA1!q3*S),-%&&Kd)*S),1!jA1!\8(S1!jAK$A1!%&+!V), p.4

, J/)&8.I9)!*/%&C)'!%&+!4-9%4,)+!73&*.48&!87!+)&+,4.4*!*)((!'3P')

!. and =. 48&amp;%(!%&amp;%,

. *!%,

J. , %. V%, and .. 4. &gt;a!rwf##ta!, 3=)&4()!4+489%./4*!%

J. , ). Va1!o*/v%, &. &amp;p, and . 3&amp;&amp;),1!ma1!o%4, Kj?*S1!VA1!i),&1!jA1!i()4&K`,%&S)1!>A1!>3, 1! VA?A1!i899)('.%)..),1!BA1!d,3&&),1!>A1!$37.&),1!BA1!$)2%*81!BA1!).!%(A!RWFFYTA!J

L. ). , '9)*.4=)!'.3+I!87!23=)&4()!'98&+I(%, vol.8

!. Uama1!d3-;-%, ;. +1!$aba1!%&amp;+!d%, and . Ta!@b&gt;vk#g!@, , vol.878, pp.3-4

R. ,

;. 4&amp;ca!?a!gh9a!v)+a!clf1!e#&quot;wew, .. V%, .. 4. V%, !. &gt;a!r#kkkta, and . G774*%*i!, !RN8&+8&1!G&C(%&+T!KFL1! "D"w""YA! L%=)((41!>A1!V4C(4%=%**%1!$A1!\48(%1!OA1!L39),.81!MA1!J4

%. and !. %&amp;, L%=)((41!>A1!\%,&4),1!tABA1!o(4=)4,%1!OA1!B%'.)((1!GA1!>,C3)+%'1!oA1!V%C&%&41!>A1!J4'.8,481!>A1! L39),.81!MA1!V%C&4KV%&<8&41!OA1!t%(%''81!LA1!).!%(A!RWF##TA!>&.4&3*(

!. Wd,

. 4&amp;/%,.1!da?a1!o(%*s1!`a?a1!d%,

, 1!?ABA1!L83C=4

, LM>!,)C3(%.)'!+)=), p.89

/. B%)&amp;8 and . %p+4, 4'!)()C%&'A!M%.3,)!IBK1!kF#wkFDA!

, !$A1!d8'*81!>A1!%&+!G'98'4.81!OA!RWF#ETA!U/)!G.48(8CI!87!?3=)&4

%. @&amp;*4+)&amp;*)!%&amp;+!*/%,

, L8''8(1!VA1!i,%3'1!OA1!J4),),1!VA1!d%),v%(+1!BA1!%&+!p%C&

!. Fi1!d&quot;#wd, A!

. =%&amp;!l8-;-!va1!=%&amp;!o8, C)&1!LA1!+)!i8,.1!OA1!.)&!B%.)1!LA1!qv4&+),-%&1!>AjA1!+)!?8&C1!dA1!

$. 42s-%&amp;&apos;1!da1, !. %&amp;+!=%&amp;!\)&amp;,88421!pa?a!rwffata, and !. &gt;&amp;,

, L3P4&1!NA>A1!>-8'1!BA@A1!p%+)1!?A>A1!V%,.4&1!?ALA1!d%()1!OA?A1!N4..()1!>AjA1!t(%+-%&1

, A!N4&S%C)!'.3+4)'!v4

!. V3 and . Ia, A1!t),(8&41!\A1!p3(77,%%.1!MA1!`)4.8'%!$)!o(4=)4,%1!OAiA1!`%(*4&41!`A1! $8()<%(8=%1!JA1!>(

, +!.8!,)'98&+!.8!'.%&+%,+!+8')'!, vol.87

!. O*/v% and .. &lt;1!la1!&gt;,

*. %&amp;+!&apos;%7).i!,